Podcasts about psychology neuroscience

Tommy spends some time with Dr. Brian Hare, author of Puppy Kindergarten and a Professor of Psychology & Neuroscience at Duke University. He runs the Duke Canine Cognition Center You can get a copy of Dr. Hare's book here: https://www.amazon.com/Puppy-Kindergarten-Science-Raising-Great/dp/B0CGS38TNG

Wellness + Wisdom | Episode 719 Wellness + Wisdom Podcast Host, Josh Trent, and the episode Co-Host, Mar, discuss the complex nature of self-care, why the mainstream media often promotes superficial products rather than addressing genuine needs, the distinction between instant gratification and delayed rewards, and the importance of having an awareness practice. Join The Liberated Life Tribe We ALL have problems. Stop hiding. Start living life liberated. Learn how to set yourself free from self-sabotage, limiting beliefs, thoughts + behaviors so you will have lifelong confidence + clarity of purpose through a thriving community + practical tools, guiding you to play a new reality game. What you get: • Discover lifelong confidence, clarity, and a true sense of purpose with practical tools and a supportive community. • Learn to rewrite your reality + master a new “reality game.” • Unlock your highest potential in your physical, mental, emotional, spiritual + financial SELF beyond your wildest dream through accessing the power of surrender to trust life + create new results. Join the Tribe

The glucagon-like peptide 1 (GLP-1)–based diabetes and obesity drug semaglutide, with trade names Ozempic and Wegovy, will become the second best-selling drug in 2024, with estimated worldwide Ozempic sales of US ~$16 billion. Finally, the pharmacological treatment of obesity seems to have a breakthrough after decades of setbacks, with previous weight-loss medications withdrawn from the market because of serious side effects. In this podcast, the co-author of a guest editorial, “Glucagon-Like Peptide 1 Receptor Agonists in Psychiatry,” Hubertus Himmerich, MD, reviews the implications of GLP-1 drugs for psychiatry and healthcare globally. The article is published in the May/June 2024 issue of the Journal of Clinical Psychopharmacology. Dr. Himmerich, who is from the department of psychological medicine, Institute of Psychiatry, Psychology & Neuroscience at King's College in London, authored the editorial with Dr. Susan L. McElroy, of the Lindner Center of HOPE, Mason, OH, and the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine.

Traditional clinical weight loss interventions can be costly, time consuming, and inaccessible to low-income populations and people without adequate health insurance. Today's guest, Dr. Gary Bennett, has developed an Interactive Obesity Treatment Approach, or iOTA for short, that represents a real advance in this area. Dr. Bennett is Professor of Psychology and Neuroscience, Medicine and Global Health at Duke University, where he is also Dean of Trinity College of Arts and Sciences. Interview Summary You know, in this time when people are talking about more expensive, and kind of more intrusive interventions, like the big weight loss drugs, it's nice to know that there may be alternatives that could be accessible to more people. Could we start off with you telling our listeners what the iOTA approach is and how it works? Sure. This is an approach for weight management. It's useful for weight loss or preventing weight gain or maintaining one's weight after you've lost weight. The idea here is that it's a technology that's designed to be highly accessible, and useful for a range of different types of populations. So, as you described, we have developed and tested this primarily for folks who are medically vulnerable, who are low income, who are racial, ethnic minority, who live in rural communities, and where we have traditionally had real difficulty reaching populations with effective weight loss tools. So, iOTA is a fully digital approach. It uses technologies smartphone apps, but it can also use text messaging, interactive voice response, those are like robocalls, automated telephone calls, websites. We've tested this on a wide range of different types of technology platforms, and we've tested it in a range of different types of populations all over the country and indeed even in other countries. So, give us some examples of what kind of information people might be receiving through these various forms of media. The underlying kind of technology, the underlying approach, I should say, for iOTA is actually reasonably simple. It operates from the perspective that creating weight loss is really about making an energy deficit. That is to say, helping people to consume fewer calories than they are expending. The realization we had years ago is that you can get there, you can create that calorie deficit in a whole host of different ways. Some people diet, some people try to get more active, there are limitations around that kind of approach. But fundamentally, you can also just get there by asking people to do some reasonably straightforward behaviors. Like not consuming sugary beverages, or consuming fewer chips, cookies and candies. Or changing the amount of red meat that they put on the plate. And, if you frame those things out as goals, then you can prescribe those goals to people in ways that make sense to them personally. The trick though is actually in the idea of personalizing those goals to the given individual. And that's where technology comes in and gets very helpful. The case is, if you have a large library of these goals, you'd want to try to provide these in a highly personalized way. That really are aligned with what people's needs are and noting that those needs may change over time. So, what we do with iOTA is deliver a very short survey. That survey then helps us to be able to look into our library of goals and pick the ones that are most useful for our users. We prescribe those goals, and then we ask folks to self-monitor those goals. Self-monitoring or tracking is an extraordinarily powerful part of behavior change science. And so, we ask them to track using one of our technologies: the chat bot or the text message or interactive voice response or the smartphone app. Every time that we receive data from one of our users, we give them highly personalized feedback that is designed around principles of behavior change science. And then over time we also give them support. We do support sometimes from a coach or sometimes from a layperson, sometimes it's even from a physician. And over time what we find is that this kind of an iOTA approach helps people to lose weight, prevent weight gain, have weight loss maintenance, but it also has a cascade of other types of effects, some of which we didn't really even anticipate producing. This reminds me of something that I've fought for years, that nutrition and weight control can get incredibly complicated and down on the weeds in a fascinating way from a academic point of view. But that you can get to the goal line with just a few simple things. You might be 80% to the goal line just by eating less junk food and eating more fruits and vegetables and getting mired in that last 20% becomes confusing. It sounds like that's exactly what you're doing. That you kind of picked some of the big things that people can do, establish goals around them, and then provide a behavioral path for getting to those goals. That's precisely our thinking. And the thing I'd add to that is part of the challenge in weight control is making those types of changes for long amount period of time that it takes to produce and sustain weight losses. One of the things we know is that any kind of behavior change, but particularly behavior change for weight control purposes just requires an extraordinary amount of engagement over a very, very long time. So, I'm fond of saying to our teams and to others I'm really much less concerned with strategies that produce weight changes at a month or two months. Because the real question for us is how do we create technologies that can support users as they enter the 10th month or the 12th month? Fundamentally, what we're really after here. It's not really weight loss, but it's really the changes in a whole range of health parameters. So cardiometabolic function, the indicators of the development of various cancers, diabetes parameters, those kinds of things. And it takes time and effort to produce those changes via the weight control, changes that we're hoping to produce with these technologies. What kind of results are you getting from this and does the iOTA program in fact make it easier for people to stay on track with their health goals? Yes, it's a really interesting set of findings over more than a half dozen trials in the last bunch of years. If I were to summarize, I'd say we get pretty modest weight losses relative to say, what you might get with a very intensive weight loss intervention or with a drug or certainly with surgery. But what's different is that those weight changes do tend to be sustained over time. So, they're modest, but they last. And the really interesting finding for us is that people stay very engaged with these technologies. On average, people tend to use new apps pretty feverishly in the first month after they downloaded, or they put it on their phone one way or another. And then most people, about 70% of the time, people move away from those apps, they disengage. When we look back about a year after people started using iOTA, it's very, very common for people to be engaged with our technologies 80-85% of the time. That is to say, they're still tracking their goals at about 80% fidelity after a year. That's really terrific. and it's one of the reasons I think that we're able to see sustained losses, even though those losses aren't very large. And again, my goal here is much less - this is a public health approach - I'm much less interested here in trying to produce large weight losses for cosmetic reasons and those kinds of things. This is really an effort to try to create a very highly disseminatable, inexpensive treatment that is accessible to large numbers of folks. In trials, we certainly have seen changes in blood pressure and various cardiometabolic parameters like lipids. Those changes tend to be larger in certain populations. When we tested this in China, we saw very, very large dips in lipids. And those too also do tend to be sustained. The biggest surprise for us over the years has been a relatively consistent set of findings that suggest that people have improved wellbeing on the backend of participating in one of these kinds of treatments. They tend to feel less stressed, have more energy, and have better quality of life. In fact, we've seen very, very large reductions in depressive symptoms in study after study. I'll just add tangentially that's notable for us in the populations in which we work, because these are not populations for whom weight is very closely tied with one's emotional state. That is to say, the patient populations in which we work tend to have more tolerance for heavier body weights compared to other populations. So, when we see weight loss in our trials, we don't often expect to see that accompanied by improvements in depressive symptoms. But we see it in study after study after study. So, we've been really pleased with this broad array of impacts that this technology seems to produce. It's nice to hear the positive results. And I also like your aspirations because a smaller weight loss, better maintained is a much better outcome than a larger weight loss regain, which is typically the case. And the fact that you're getting these corollary effects in other areas of life, like mental health and things like that is very impressive. Are there other stories you could tell from people that have been on the program that might be illustrative? Oh yes. What happens most often in our studies is that at some point one of our patients approaches me and says, "You know, I've tried everything. I've tried dieting, tried this app and that app and this is just so easy. I've been able to stick with it for a long time." That happens a lot. And it always, always pleases me greatly because at the end of the day we're really trying to create these technologies for real people to use over a very, very long period of time. I find that exciting. We've had a number of people over the years who have gotten off their hypertension medications or have had seen changes in their diabetes, their A1Cs as a measure of diabetes. And it's just really exciting because then it's one of the things that I think gets us up in the mornings to do this work. That is exciting. How has it been especially influential among people who otherwise have limited access to care? We really started this work because of a series of observations that I made early in my career when I started working in community health centers. Community health centers are often primary care units in many major metropolitan areas, and often in rural settings as well. Their primary intention is to serve patients who are medically vulnerable, and often patients who are poor. On those settings, the providers in those settings are just doing extraordinary work. And I started to spend time there and was trying to understand how we might think about situating this kind of technology and these kinds of public health style interventions within those care settings. And the observation I made over and over and over again was that, even in these care settings that are really designed to serve patients who have low income or come from limited income backgrounds, weight control and behavior change in general was just not the highest priority. These physicians are dealing with all manner of acute and chronic health crises. And they just didn't feel that managing a patient's weight was the best use of their limited clinical time and attention with patients. The challenge of that, of course, is that, for patients who have obesity, that can be a primary cause of many of the acute and chronic conditions that my physician colleagues were treating. And so what I began to observe was that patients who have the greatest need for comprehensive obesity care are often the least likely to receive it. And this is borne out by national data, which suggests that if you're a person from a medically vulnerable background and you have obesity, you're dramatically less likely to receive high quality care from the health system. And then there are a whole range of financial constraints that limit your ability to be able to acquire that care in the commercial market. And so there are really many, many people, really, tens of millions of folks out there without options. So, that's really why we started developing these tools. And I'm very pleased to say that the underlying approach that we develop with iOTA has been leveraged in a variety of weight control interventions that are being used in other places. The next frontier for us is to really think about how to disseminate this in a more widely accessible way. We've begun having conversations with metropolitan areas. Cities where health departments are thinking about doing these kinds of things. Some of these technologies have found their way into other systems. And increasingly as we have begun to test these approaches in clinical care settings, we certainly have seen ongoing use of these technologies in the community health centers where we originally came up with some of these ideas. So, much more work there to be done but I'm hopeful. Do you see a role for this approach in conjunction with or as a companion to the weight loss medications that are getting so much attention now? Yes, I do. One of the things that's notable about this generation of weight loss medications is that they do not have an indication that they should be accompanied with a behavior change intervention. So, the other way to say that is that most weight loss drugs that we've seen in years past have received FDA approval, contingent on their combination, their use, alongside a behavior change intervention. And the GLPs, the ones that are most recently emerged, don't have that indication. Nevertheless, we know a couple of things. One is that these are medications that are designed to be used for very long time in order for fat, weight loss to be sustained. And there are a number of people who increasingly are interested in transitioning off of these medications and beginning to engage weight control on their own. So, my sense is that technologies like iOTA can be very useful in helping people make those transitions off of drug. I think the technologies we've created can be very, very useful as an adjunct to try to help to maintain motivation for weight loss. And to think about addressing some of the related behaviors that can help people to experience an overall improvement in their health. So, becoming more physically active and making changes in stress and wellbeing as an adjunct to the weight loss that's being produced by the drugs. I have to tell you, I'm very, very concerned about the cost of these medications. I'm very pleased by their efficacy, but I'm extraordinarily concerned about their cost and their limited accessibility. I expect that will change. But during this period of time, I'm very concerned about the creation of additional disparities, patient's ability to seek really high-quality care. I'm glad you raised that point. So, where do you see the work going next with IOTA? Well, I see it going in two directions. One, we are thinking about dissemination. Where can you embed this kind of approach inexpensively in ways that allow the greatest number of users. The emergence of artificial intelligence technologies, notably the large language models, really help in that regard because they allow us to deliver that kind of core iOTA special sauce more flexibly in a range of different technologies. And even more inexpensively than we can do right now. iOTA is extremely cost effective and with AI delivery it could be even more so. And then the other path I see is really what you asked before. And it's how do we think about using these technologies as an adjunct to medication treatment, which I think will become even more common over the next couple of years. I hope that it becomes a more common approach that's used to treat the patients who have the highest risk of obesity and all of the chronic health conditions that travel along with it. Bio Gary Bennett, a professor in the department of Psychology & Neuroscience who also holds appointments in Global Health, Medicine and Nursing, is the founding director of the Duke Digital Health Science Center. For 20 years, he has been studying how incorporating digital strategies into clinical treatment of obesity can improve health outcomes. His development of the Interactive Obesity Treatment Approach (iOTA) has been supported by over $20 million in grants from the National Institutes of Health.

In this episode of the Refrigeration Mentor podcast, host Trevor Matthews talks with “The HVAC Doctor” Matt Waxer about using social media to help educate people. From programming boards, to understanding filters and explaining all of the parts of a compressor, Matt's highly engaging social media videos offer free education and information for followers, fellow mechanics, cohorts, apprentices and business owners - something he believes elevates the HVAC industry collectively. And Matt doesn't come by the title “Doctor” loosely - he's a 313A Red Seal Refrigeration and Air Conditioning System Mechanic, Gas Fitter, and holds a Ph.D in Psychology/Neuroscience. In this episode, Trevor and Matt discuss: Getting into education so you  don't get stuck in the field Sharing free information to empower people in the industry vs holding onto knowledge for the sake of job security Getting over the fear of putting yourself out there The formula for an engaging social media video Dealing with negativity on social media Incorporating confidentiality on the job site Benefits of doing educational videos on social media Tips for shooting good videos on the job site How to get better engagement on your social media posts Being your authentic self on social media Different platforms for different audiences Tip for getting started making social media content Useful tools and apps for creating social media content Helpful links and contacts: Follow Matt Waxer “The HVAC Doctor” on Instagram | Facebook | TikTok Connect with Matt on LinkedIn Social Media Tools: Veed.io | BigVU REGISTER HERE for the next 12 Week Advanced CO2 Design Course (starts May 2024). Refrigeration Mentor on Instagram Refrigeration Mentor YouTube Channel Upcoming Servicing Compressors, Supermarket and CO2 Trainings: Learn More Here Learn More About Refrigeration Mentor: https://refrigerationmentor.com/ Get your FREE Service & Compressor Troubleshooting Guide: Access Here  

Have you ever wondered why we DON'T feel bad for rich people? This is a very intriguing episode of my podcast where I delve into the paradoxical concept of empathy towards the rich and powerful people of the world. I explained the psychological phenomenon known as Hedonic Adaptation (Hedonic Happiness or the Hedonic Treadmill) and its profound implications on our perceptions of wealth and happiness. Contrary to conventional and popular beliefs, I explore the thought provoking reason why it's not valid to dismiss the feelings of those who seemingly have it all, but rather see them for what they really are.. HUMAN. Through a compelling exploration of positive psychology, this podcast is meant to challenge existing narratives, offer a fresh perspective on the emotional experiences of the wealthy, and reshape your understanding of wealth, happiness, and emotional wellbeing. Hi, I'm Anjy :) This is a British Podcast about Dating & Relationships, Self Development, Psychology & Neuroscience, Self Love and Happiness. I believe I can inspire people to get up when they feel down, go for opportunities they don't feel qualified for, and never feel bad for doing what's truly best for them. No, you don't have to settle for mediocre. You CAN have the BEST of the BEST of EVERYTHING!

Does Money *truly* Make You Happy? Let's explore the fascinating world of the rich, where WEALTH is the goal, and HAPPINESS is supposedly an afterthought. What is the relationship between money and happiness? This eye-opening research by 3 psychologists reveals the surprising connections between Income and Wellbeing. It challenges common and popular beliefs that money does not make us happy, and hints at the secret to lasting happiness. So... Can money truly buy happiness? Let's get into out! Here's what you'll get from this video: 1) The 3 component of Happiness (using the knowledge of neuroscience & psychology). 2) I explored 3 research papers on positive psychology and made a very intriguing discovery about the hidden connections between money and happiness. 3) This research backed podcast also discusses experienced well-being vs evaluative well-being, relative to your income. 4) Lastly, I reference Hedonic Adaptation (which you can learn more about in my next YouTube video) Now you know, and you no longer have to search "does money make you happy on YouTube".. you welcome :) 00:00 Hook 00:23 Intro 00:58 3 Drivers of Happiness 02:11 The 3 Studies on the relationship between Money & Happiness 02:21 Experienced Well-being 02:38 Evaluative Well-being 02:51 Study No.1 04:41 Study No.2 06:22 Happiness Adaptation 06:47 Study No.3 10:48 The Result 11:45 Biased Result? 12:57 A question for YOU 14:08 It gets even more interesting 16:33 The secret to happiness? 18:16 Takeaways 19:05 More psychology & neuroscience Hi, I'm Anjy :) This is a British Podcast about Dating & Relationships, Self Development, Psychology & Neuroscience, Self Love and Happiness. I believe I can inspire people to get up when they feel down, go for opportunities they don't feel qualified for, and never feel bad for doing what's truly best for them. No, you don't have to settle for mediocre. You CAN have the BEST of the BEST of EVERYTHING!

In today's episode, Ashanti Bentil-Dhue has a captivating conversation with Ruth Kudzi, the CEO and founder of Optimus Cage Academy. During their interview, they will dive deep into the world of coaching and the pressing need for accreditation within the industry. Exploring the significance of accreditation, how it can elevate your coaching practice, uncovering the true essence of coaching, its empowering nature, and the long-lasting impact it can have on clients. Discover the benefits of becoming an accredited coach and how it not only enhances your credibility but also contributes to a more equitable coaching landscape.  If you're curious about the future of coaching, the role of accreditation and professional growth, this episode is a must-listen. "Coaching is about unlocking what's inside of a person, making change more sustainable, not just addressing a knowledge gap. Accreditation brings credibility, ethical practice, and the ability to charge more, ultimately elevating the coaching industry's standards and impact."      Episode Highlights:  Why is there a need for more qualified coaches in the DEI industry? Emphasizing the importance of coaching as a non-directional, empowering, and dignifying process that unlocks answers within clients.  Potential for coaching to promote equity and social mobility by reaching high-potential individuals from diverse backgrounds.   About Ruth Kudzi: Ruth Kudzi is an entrepreneur and educator: She runs a training business , Optimus Coach Academy and a coaching & mentoring business. Optimus is one of the market leader training providers in the UK providing accredited coach training with 4 different bodies. Ruth is a Master Certified Coach, Psychology & Neuroscience expert with numerous qualifications in Psychology including a BA, MA and PGCERT. She is a multiple best selling author, international speaker and podcaster: her whole mission is around supporting people to feel better and build their resilience to achieve the results they want to achieve.  If you would like to apply to be a guest on the show email: operations@goodsoilleaders.com   If you would like to schedule a capability briefing call with our team, email: operations@goodsoilleaders.com    If you would like to apply for DEI PRO Coaching, email: operations@goodsoilleaders.com  Stay Connected with Ashanti:  LinkedIn: Ashanti Bentil-Dhue

Recent psychological studies find that gratitude can help us create, cultivate, and maintain the kinds of relationships that make life worth living. Other studies are finding that gratitude is far more complicated, and plays a nuanced role in our complex emotional lives. Research psychologist Jo-Ann Tsang (Baylor University) joins Ryan McAnnally-Linz to talk about the complicated emotional world that gratitude inhabits, the scientific study of giving thanks and the contexts where its prosocial or adaptive for us, the dark side of gratitude, and the role it plays in a life of flourishing. This episode was made possible in part by the support of the Gratitude to God Project.About  Jo-Ann TsangJo-Ann Tsang is a social psychologist, and is Associate Professor of Psychology in the Department of Psychology & Neuroscience at Baylor University.Show NotesGratitude to God Project Website: Psychological, Philosophical and Theological InvestigationsTryptophanic food coma dreams of John Madden ranting about football and turduckenDaniel Tiger: “Sometimes you feel two feelings at the same time, and that's okay.”Empirical psychological research on gratitudeIntrinsic vs instrumental reasons for being gratefulSelf-determination theoryThe downsides of gratitudeGratitude in marriage: matching affective responses of support and gratitude in relationshipsGratitude toward GodJulie Exline on Spiritual Struggle (link)“It's not always adaptive to be happy?”Prosocial behaviorFind, Remind, Bind TheoryWhat is pro-sociality?What is adaptivity?Happiness is not always adaptive.What's adaptive depends on your goal in a certain situation.Happiness and adaptivity as malleable concepts that depend on your definition of the good.Does gratitude reduce protest?Increased forgiveness and willingness to accept oppression rather than oppressionQuietism and perpetuating unjust structuresGratitude might put on the brakes for the motivation to protest or press for change“Give thanks in all things.” vs “Give thanks for all things.”“Life is complicated.”Gratitude doesn't rule out anger“How can I feel happy when there's all these bad things going on?”Is gratitude related to prejudice, stigma, or discrimination?Why is it we keep chasing after happiness?“If you're in a bad relationship, and gratitude's making you stick more strongly with that relationship partner, then that's not good.”The role of gratitude in a life worth livingProduction NotesThis podcast featured research psychologist Jo-Ann Tsang and theologian Ryan McAnnally-LinzEdited and Produced by Evan RosaHosted by Evan RosaProduction Assistance by Macie Bridge and Kaylen YunA Production of the Yale Center for Faith & Culture at Yale Divinity School https://faith.yale.edu/aboutSupport For the Life of the World podcast by giving to the Yale Center for Faith & Culture: https://faith.yale.edu/give

Why do people love things? Can you really love a thing like you love a person? What are the main reasons people fall in love with brands and things? How can companies get consumers to love their products more? How future technology will create much greater levels of emotional attachment between people and things? Why do we love music? Aaron Ahuvia, Ph.D. answers the above questions and many more. Dr. Ahuvia is the world's leading expert on brand love, a topic he pioneered and has worked on since 1990. Dr. Aaron Ahuvia is the Professor of Marketing at the University of Michigan-Dearborn College of Business. He received his Ph.D. in Marketing from Northwestern University's Kellogg College of Business where along with conducting original research, he assisted Professor Phillip Kotler with a revision of his classic textbook. Please follow/connect on Linkedin : https://www.linkedin.com/in/aaronahuvia/ Please visit Dr Aaron's Website : https://thethingswelove.com/ Aaron Ahuvia's book : https://www.amazon.com/Things-We-Love-Passions-Connect-ebook/dp/B09L81SC2M Jagged with Jasravee is facilitated by Jasravee Kaur Chandra, Director- Brand Building, Research & Innovation at Master Sun, Consulting Brand of Adiva L Pvt. Ltd. Jasravee has over 20 years experience as a Strategic Brand Builder,Communications Leader and Entrepreneur. Please visit Jasravee at https://jasravee.com/ Connect with Jasravee on Linkedin at https://www.linkedin.com/in/jasravee/ Email Jasravee at jasravee@theadiva.com Index 00:00 Preview & Introduction to Dr. Aaron Ahuvia 03:01 From World's First Dating Service to Brand Love 08:00 Why People Love Things 11:11 Most Loved Brands - Being Fabulous & Different Isn't Enough 19:13 How Can Brands Create Love - 3 Kinds of Connection 26:17 Mobile Phone Love - Makes All 3 Connections 28:18 Evolutionary Basis of Love in Humans & Some Animals 35:45 Future Trends In Love of Things 39:45 Love of Categories, Creating More Love Than Competition 47:55 Why We Love Music 51:16 Rapid Fire - Personally Speaking with Professor Aaron Ahuvia 55:39 Connecting with Dr Ahuvia Follow Jagged with Jasravee on Social Media Campsite One Link : https://campsite.bio/jaggedwithjasravee Facebook Page : https://www.facebook.com/jaggedwithjasravee Instagram : https://www.instagram.com/jagggedwithjasravee/ Podcast Page : https://anchor.fm/jagged-with-jasravee Youtube Page : https://www.youtube.com/c/jaggedwithjasravee Jagged with Jasravee, is an initiative of Master Sun, the Consulting Brand of Adiva Lifestyle Pvt Ltd. Website : https://jasravee.com/ #mostlovedbrands #loveofbrands #brandlove #loveofthings #neuropsychology #brandpreference #consumerpreference #Loveofobjects #anthropomorphism #Anthropomorphic #brandloyalty #customerloyalty

Melissa gravitates towards topics such as: Abusive Relationships, Finding your identity in Christ, Deconstruction, Psychology/ Neuroscience and the Bible, Parenting, and ADHD. She has a passion to see women discover their true value and to find real relationship with Jesus. It is her mission to help as many women as she can show up in this life mentally, spiritually, emotionally, and physically healthy, whole and functional. Check her out at https://cometothetablepodcast.com/meet-the-ladies/Valuable Voices Podcast with MirandaAdding value to the world with amazing people who have made an impact on my life and others that I can't help but share with you!Apply to be interviewed here - https://linktr.ee/mkward7878Check us out on:Youtube - https://youtu.be/E0AKOMNjC0kFacebook - https://www.facebook.com/valuablevoicespodcastBuzzsprout - https://valuablevoices.buzzsprout.com/Apple - https://podcasts.apple.com/us/podcast/valuable-voices-podcast-with-miranda-ward/id1529343260

Tim is a lifelong inventor, and student of everything.He lives in Japan while helping business leaders and their senior leadershp all over the world use their brains better.aches them to use simple modern & ancient techniques that are verified by cognitive neuroscience.He also just happens to have ADHD, which he only discovered at the end of his B.Sc. in Psychology Neuroscience while doing his 4th year term paper.He phoned his mum to confirm his suspicions to which she laughed, then said " I could have told you that. "He is very passionate about science, success, and helping people achieve their ikigai through scientific principles.Email: tim@crush-it-club.comYouTube: Crush It ClubMentioned in this episode:ADHD CourseJoin us for the first run of the Successful ADHD Entrepreneur Course starting April 20th. Learn about mindset, systems, processes, and tools that Michael Whitehouse uses to make people think he's really organized. First session limited to 20 students, so apply now.ADHD CourseADHD CourseJoin us for the first run of the Successful ADHD Entrepreneur Course starting April 20th. Learn about mindset, systems, processes, and tools that Michael Whitehouse uses to make people think he's really organized. First session limited to 20 students, so apply now.ADHD Course

Welcome back, friends! Apologies for the brief delay in getting this episode out. We're now happily back on track and super stoked for what we have coming up—starting with today's episode. My guest is Dr. Michael Tomasello, a voraciously interdisciplinary thinker, an incredibly productive scientist, and a pioneer in the systematic comparison of chimpanzee and human capacities. Mike is a Distinguished Professor in the department of Psychology & Neuroscience at Duke University, where also holds appointments in Evolutionary Anthropology, Philosophy, and Linguistics. He is the author of growing list of influential books, including the recent Becoming Human: A Theory of Ontogeny and a new book coming out this fall titled The Evolution of Agency. In this conversation, Mike and I talk about how he came to study both children and chimpanzees. We discuss the challenges of working with each of these groups—and the challenges of comparing them. We talk about some of the key concepts that have figured prominently in Mike's work over the years—like joint attention and false belief—and well as some of the concepts he's been elaborating more recently—including norms, roles, and agency. We also discuss Vygotsky and Piaget; how humans got started down the path toward intense interdependence and cooperation; and what Mike thinks he got wrong earlier in his career. Lots in here, folks—let's just get to it. On to my conversation with Dr. Michael Tomasello. Enjoy!   A transcript of this episode will be available soon.   Notes and links 3:30 – Early in his career, Dr. Tomasello was affiliated with the storied Yerkes Primate Center. 5:00 – Major works by Lev Vygotsky (in translation) include Mind in Society and Thought and Language. 7:00 – A video about some of the early work of Wolfgang Kohler. 10:30 – Dr. Tomasello is the Emeritus Director of the Max Planck Institute for Evolutionary Anthropology in Leipzig. 17:00 – A chapter outlining some key results of “looking time” (or “preferential-looking”) experiments in developmental psychology. 21:00 – A recent article by Cathal O'Madagain and Dr. Tomasello about “joint attention to mental content.” 25:00 – A paper by Holger Diessel on demonstratives and joint attention. 25:00 – A video describing work that Dr. Tomasello and colleagues have carried out on chimpanzee theory of mind. A 2019 general audience article summarizing the state of this research. 28:00 – Dr. Tomasello's book on child development, Becoming Human: A Theory of Ontogeny, was published in 2018. 31:00 – A recent paper by Dr. Tomasello on the importance of roles in human cognition and social life. 34:00 – A recent paper by Dr. Tomasello on the psychology behind the human sense of obligation. 35:00 – A paper of Art Markman and C. Hunt Stillwell on “role-governed categories.” 36:00 – A paper by Christophe Boesch on “cooperative hunting roles” among chimpanzees. 38:00 – A very recent paper by Dr. Tomasello, “What is it like to be a chimpanzee?” 39:15 – A study by Dr. Tomasello and colleagues about whether apes (and children) monitor their decisions. 40:45 – Dr. Tomasello's most cited book, The Cultural Origins of Human Cognition, was published in 2001. 43:00 – Dr. Tomasello's next book, The Evolution of Agency, will be published in September by MIT press. You can read more about Dr. Tomasello's work at his website.   Many Minds is a project of the Diverse Intelligences Summer Institute (DISI) (https://disi.org), which is made possible by a generous grant from the Templeton World Charity Foundation to UCLA. It is hosted and produced by Kensy Cooperrider, with help from assistant producer Cecilia Padilla. Creative support is provided by DISI Directors Erica Cartmill and Jacob Foster. Our artwork is by Ben Oldroyd (https://www.mayhilldesigns.co.uk/). Our transcripts are created by Sarah Dopierala (https://sarahdopierala.wordpress.com/). You can subscribe to Many Minds on Apple, Stitcher, Spotify, Pocket Casts, Google Play, or wherever you like to listen to podcasts. **You can now subscribe to the Many Minds newsletter here!** We welcome your comments, questions, and suggestions. Feel free to email us at: manymindspodcast@gmail.com. For updates about the show, visit our website (https://disi.org/manyminds/), or follow us on Twitter: @ManyMindsPod.

#consciousness #awareness #AST #neurosceince #michaelgraziano Michael Graziano is an Author, scientist, professor of psychology, and neuroscience at Princeton University, his lab/research focuses on the brain basis of consciousness. The attention schema theory of consciousness proposes that an attention schema is like the ‘body schema'. Just like the brain constructs a simplified model of the body to help monitor and control movements of the body, so the brain constructs a simplified model of attention to help monitor and control attention. Information in that model, portraying an imperfect and simplified version of attention, leads the brain to conclude that it has a non-physical essence of awareness. He Posits Consciousness is informational & mechanistic in nature and not magical or mysterious, in theory when we have the technology to scan/upload our cognitive data onto a computer/avataar/robot/machine we will be able to transfer consciousness too. https://grazianolab.princeton.edu/ https://www.linkedin.com/in/michael-graziano-0490188a links https://en.wikipedia.org/wiki/Attention_schema_theory https://youtu.be/2DWnvx1NYUA https://youtu.be/q_TyuQU7epQ https://youtu.be/CgFzmE2fGXA https://youtu.be/YWQnzylhgHc Watch our highest viewed videos: 1-India;s 1st Quantum Computer- https://youtu.be/ldKFbHb8nvQDR R VIJAYARAGHAVAN - PROF & PRINCIPAL INVESTIGATOR AT TIFR 2-Breakthrough in Age Reversal- -https://youtu.be/214jry8z3d4DR HAROLD KATCHER - CTO NUGENICS RESEARCH 3-Head of Artificial Intelligence-JIO - https://youtu.be/q2yR14rkmZQShailesh Kumar 4-STARTUP FROM INDIA AIMING FOR LEVEL 5 AUTONOMY - SANJEEV SHARMA CEO SWAAYATT ROBOTS -https://youtu.be/Wg7SqmIsSew 5-TRANSHUMANISM & THE FUTURE OF MANKIND - NATASHA VITA-MORE: HUMANITY PLUS -https://youtu.be/OUIJawwR4PY 6-MAN BEHIND GOOGLE QUANTUM SUPREMACY - JOHN MARTINIS -https://youtu.be/Y6ZaeNlVRsE 7-1000 KM RANGE ELECTRIC VEHICLES WITH ALUMINUM AIR FUEL BATTERIES - AKSHAY SINGHAL -https://youtu.be/cUp68Zt6yTI 8-Garima Bharadwaj Chief Strategist IoT & AI at Enlite Research -https://youtu.be/efu3zIhRxEY 9-BANKING 4.0 - BRETT KING FUTURIST, BESTSELLING AUTHOR & FOUNDER MOVEN -https://youtu.be/2bxHAai0UG0 10-E-VTOL & HYPERLOOP- FUTURE OF INDIA"S MOBILITY- SATYANARAYANA CHAKRAVARTHY -https://youtu.be/ZiK0EAelFYY 11-NON-INVASIVE BRAIN COMPUTER INTERFACE - KRISHNAN THYAGARAJAN -https://youtu.be/fFsGkyW3xc4 12-SATELLITES THE NEW MULTI-BILLION DOLLAR SPACE RACE - MAHESH MURTHY -https://youtu.be/UarOYOLUMGk Connect & Follow us at: https://in.linkedin.com/in/eddieavil https://in.linkedin.com/company/change-transform-india https://www.facebook.com/changetransformindia/ https://twitter.com/intothechange https://www.instagram.com/changetransformindia/ Listen to the Audio Podcast at: https://anchor.fm/transform-impossible https://podcasts.apple.com/us/podcast/change-i-m-possibleid1497201007?uo=4 https://open.spotify.com/show/56IZXdzH7M0OZUIZDb5mUZ https://www.breaker.audio/change-i-m-possible https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xMjg4YzRmMC9wb2RjYXN0L3Jzcw Kindly Subscribe to CHANGE- I M POSSIBLE - youtube channel www.youtube.com/ctipodcast

"Doctors for Assange began writing to governments in late 2019 warning that Julian Assange was in a fragile state of health, and could die in prison. We have repeatedly called for his release on urgent medical grounds. Since then, medical experts who examined Julian Assange testified in court to the seriousness of his medical condition. They explained that he would not survive oppressive prison conditions, and his extradition to the United States was denied on those grounds. The High Court subsequently stood by the medical findings, and ruled that the medical evidence could not be challenged. Meanwhile, having won his case, Julian Assange remains in the very conditions that caused and perpetuated his precarious state of health in the first place. With appeals set to drag on for years, unless Julian Assange is released from prison, there is every reason to expect his condition to deteriorate, potentially dramatically so. Given the medical evidence that is openly on the table now, Doctors for Assange warns that Julian Assange may not survive the appeal process." GUESTS Dr. Bob Gill, MBChB, MRCGP, General Medical Practitioner; writer and producer of the film, 'The Great NHS Heist', United Kingdom Prof William Hogan, MD, Specialist in Internal Medicine; Professor of Biomedical Informatics, United States Dr. Lissa Johnson, PhD, Clinical Psychologist and writer, Australia Dr. Jill Stein, MD, Internist, Lexington, Massachusetts; Former instructor in Medicine, Harvard Medical School, two-time US presidential coandidate, United States Dr. Derek Summerfield, Honorary Senior Clinical Lecturer, Institute of Psychiatry, Psychology & Neuroscience, King's College, University of London; Former Chief Psychiatrist at the Medical Foundation for Victims of Torture, United Kingdom Dr. Sue Wareham OAM (Order of Australia), MBBS, General Medical Practitioner (retired); Co-founder of ICAN, the International Campaign to Abolish Nuclear Weapons, which was awarded a Nobel Peace Prize in 2017, Australia SHOW LESS

Biden jokes about expanded fight with Russia: 'If I gotta go to war, I'm going with you guys' Biden tells union workers, 'This fight is far from over' https://www.foxnews.com/politics/biden-jokes-war-russia-ukraine-union-sanctions President Biden joked about the possibility of the Russian invasion of Ukraine to expand to directly involve the U.S. military on Wednesday, telling union workers, "If I gotta go to war, I'm going with you guys." Biden made the statement during an address to union workers at the North American Building Trades Unions legislative conference Wednesday. Biden opened his speech with a lengthy section addressing new sanctions against Russia. "This fight is far from over," Biden said. "Here's the point: This war could continue for a long time, but the United States will continue to stand with Ukraine and the Ukrainian people in their fight for freedom." "And by the way, if I gotta go to war I'm going with you guys. I mean it," he added. Biden's statement comes after months of he and other administration officials stating that the U.S. will not deploy troops to Ukraine. The U.S. military has limited its deployments to nearby NATO countries, and warned Russian President Vladimir Putin that invasion of one of those countries would mean direct war with the U.S. --------------------------- In fiery speech, Ukraine's Zelensky implores U.N. Security Council to hold Russia to account https://ca.news.yahoo.com/zelensky-address-security-council-renewed-115338286.html Ukrainian President Volodymyr Zelensky, in an impassioned address to the U.N. Security Council on Tuesday, likened perceived Russian atrocities in his homeland to Nazi war crimes, calling for Nuremberg-style tribunals to hold Moscow accountable. “They shot and killed women outside their houses. They killed entire families, adults and children, and they tried to burn the bodies,” Zelensky said in a video appearance before the Security Council, a day after an emotional visit to the ravaged town of Bucha, outside the capital, Kyiv. “They cut off limbs, slashed throats, raped women in front of their children," the Ukrainian leader said in his most forceful excoriation to date of the Russian invasion. In a perhaps risky strategy of sharply criticizing the body from which he is seeking help, Zelensky issued a stark challenge to world institutions such as the United Nations to make sweeping changes to the global security architecture, asking sardonically at one point: "Are you ready to close the U.N.?" “It is obvious that the key institutions of the world … simply cannot work effectively,” said the 44-year-old president, who has won worldwide accolades for presiding over his compatriots' fierce and sustained resistance to the Russian attempt to subjugate Ukraine. ----------------------------- Some hoped FDA approval of Pfizer's COVID vaccine would convince unvaccinated Americans. It didn't, study finds. But a study published Wednesday in JAMA Network Open found the shift from emergency use authorization of the vaccine to full approval did not sway unvaccinated Americans. Researchers from the University of Utah analyzed vaccination data from the Centers for Disease Control and Prevention starting July 25, a month before full FDA approval, to Sept. 9, the day before President Joe Biden made his vaccine mandate announcement. Using the vaccination rate leading up to full approval, they estimated how many doses would have been administered compared to the actual recorded number. Study authors found FDA approval was associated with an overall 36% increase in vaccinations, but most were second doses. First doses, they found, were 16% lower than predicted. Health experts are not surprised by the study's findings. “The reason why people get vaccinated has very little correlation with whether or not something is approved or an EUA,” said Dr. Jay W. Lee, a family physician and chief medical officer of Share Our Selves community health center in Orange County, California, who is not affiliated with the study. ---------------------------- Anti-vaccine beliefs come from a childhood of mistrust, study claims Are recent politics really to blame for the widespread resistance to the COVID-19 vaccine? A new study suggests that the real answer may go much deeper than people think. Researchers from Duke University say the passionate opposition to vaccinations and policies like mask mandates can trace its roots back all the way to a person's childhood. Their study claims that growing up in an atmosphere of mistrust leads to these attitudes later in life. “We had so many friends and family who initially said that the pandemic was a hoax, and then refused to wear a mask or social-distance, and kept singing in the choir and attending events,” says study senior author Terrie Moffitt in a university release. “And then when the vaccines came along, they said ‘over their dead bodies,' they would certainly not get them,” adds Moffitt, Duke's Nannerl O. Keohane University Distinguished Professor of Psychology & Neuroscience. “These beliefs seem to be very passionate and deeply held, and close to the bone. So we wanted to know where they came from.” ‘Don't trust the grownups' Researchers used data from the Dunedin Multidisciplinary Health and Development Study, which has been tracking nearly all of the 1,000 people born between 1972 and 1973 from a single town in New Zealand. Researchers have been measuring each person's social, psychological, and health factors since childhood — giving scientists insights into how these early years impact adulthood. Study authors conducted a special survey of the group in 2021 to examine each participant's stance on the COVID-19 vaccine before the shots became available in the country. The team then matched each person's responses to the records on their upbringing and personality over the years. Results show that, 40 years ago, respondents who are now vaccine-resistant or express vaccine hesitancy had more adverse childhood experiences than others. These include incidents of abuse, neglect, threats, and other hardships such as poverty. -------------------------- Democrats Interrogate Oil Executives About "America's Pain At The Pump" As public opinion poll after public opinion poll has confirmed, surging gas prices is one of the most controversial issues in the US. As President Biden made clear when he announced his plans to release 180 million barrels from the Strategic Petroleum Reserve, Democrats are doing everything they can to try and blame rising prices on President Putin and the American energy industry (which Biden accused of greedily holding back on production, even though his own energy policies have made it harder for shale producers to do so). So, in their latest attempt to blame the spike in prices on evil corporate America, Democrats on the House Energy and Commerce Subcommittee on Oversight and Investigations are holding a hearing on Wednesday, where they will interrogate the CEOs of Exxon Mobil, Chevron, BP America, Shell USA, Devon Energy Corp and Pioneer about the dynamics driving the surge in prices at the pump. The title of the hearing tells one everything they need to know about the overall tone: "Gouged At The Gas Station: Big Oil And America's Pain At The Pump". In testimony submitted to the subcommittee, the oil executives explained that a combination of labor and supply shortages have stopped their companies from raising output back to pre-pandemic levels, while the price of oil and gas are largely determined by international market conditions beyond their control. Of course, this reasoning was apparently lost on the Democrats. In an interview with Reuters, Democrat members of the committee are already sharpening their knives. "We will not sit back and allow the fossil fuel industry to take advantage of the American people and gouge them at the pump," Diana DeGette, a Democrat and chair of the subcommittee, said about the hearing at which executives from Exxon Mobil, Chevron, BP America, Shell USA , Devon Energy and Pioneer will testify. "We want to know what's causing these record-high prices and what needs to be done to bring them down immediately," she said. Many Democrats have complained that oil companies have made record profits while consumers face high prices. In addition to the executives, former Trump Administration National Security Advisor HR McMaster, now a senior fellow at Stanford's Hoover Institute, will also participate. ----------------------- FEATURED GUEST NEW BOOK from #1 Nationally Bestselling Author: The Dancer and The Devil April 6, 2022, Washington, D.C.—Communism must kill what it cannot control. So, for a century, it has killed artists, writers, musicians, and even dancers. It kills them secretly, using bioweapons and poison to escape accountability. Among its victims was Anna Pavlova, history's greatest dancer, who was said to have God-given wings and feet that never touched the ground. But she defied Stalin, and for that she had to die. Her sudden death in Paris in 1931 was a mystery until now. The Dancer and the Devil: Stalin, Pavlova, and the Road to the Great Pandemic by nationally bestselling author John O'Neill and international lawyer Sarah Wynne traces Marxism's century-long fascination with bioweapons, from the Soviets' leak of pneumonic plague in 1939 that nearly killed Stalin to leaks of anthrax at Kiev in 1972 and Yekaterinburg in 1979; from the leak of a flu in northeast China in 1977 that killed millions to the catastrophic COVID-19 leak from biolabs in Wuhan, China. Marxism's dark past must not be a parent to the world's dark future. COMMUNIST CHINA PLAYED WITH FIRE AND THE WORLD IS BURNING Nearly ten million people have died so far from the mysterious COVID-19 virus. These dead follow a long line of thousands of other brave souls stretching back nearly a century who also suffered mysterious "natural" deaths, including dancers, writers, saints, and heroes. These honored dead should not be forgotten by an amnesiac government trying to avoid the inconvenient truth. The dead and those who remember and loved them deserve answers to two great questions. How? Why? The Dancer and the Devil answers these questions. It tracks a century of Soviet and then Chinese Communist poisons and bioweapons through their development and intentional use on talented artists and heroes like Anna Pavlova, Maxim Gorky, Raoul Wallenberg, and Alexei Navalny. It then tracks leaks of bioweapons beginning in Saratov, Russia, in 1939 and Soviet Yekaterinburg in 1979 through Chinese leaks concluding with the recent concealed leak of the manufactured bioweapon COVID-19 from the military lab in Wuhan, China. Stalin, Putin, and Xi, perpetrators of these vast crimes against humanity itself, should not be allowed to escape responsibility. This book assembles the facts on these cowardly murderers, calling them to account for their heartless crimes against man culminating in COVID-19.

Around the age of 14, Paul Sheesley took a psychology course in high school. About the same time, his parents gave him a book on psychology for his birthday, “Guilty by Reason of Insanity: Inside the Minds of Killers” by Dorothy Otnow Lewis. After reading the book, especially the case examples and studies, he remembers “becoming fascinated with the field [of psychology].” In fact, during his senior year, he did a practicum at Spring Grove in Maryland which is the third oldest mental health facility in the nation. He became so interested in counseling and psychology that he attended McDaniel College in Westminster, MD for his BA in psychology and neuroscience. Since then, Paul has been focused, driven, and ambitious when it comes to self-development and sharpening his clinical skills and expanding his acumen. In this podcast, Paul shares his academic and professional journey in hopes that his experiences and advice will help those interested in the field of counseling and psychology. During our discussion, he shares some of the most important opportunities in his life which allowed him to expand his education, knowledge, and experience. He continued his education by attending The Chicago School of Professional Psychology for his MA in forensic psychology. During our discussion he shared his belief in applying and improving oneself by learning, and becoming proficient in, new types of therapy. He is a schema therapist and is part of the International Society of Schema Therapy. Paul is a Licensed Professional Counselor, Licensed Clinical Professional Counselor, and a Licensed Clinical Alcohol and Drug Counselor. With almost 20 years of experience in the field of clinical psychology, Paul has his own practice in Washington, D.C. and Bel Air, MD. Through hard-work and dedication, he has built up his reputation as being one of the most notable transformational psychotherapists in the D.C. area specializing in helping politicians, C-suite executives, and other prominent people and couples to achieve balance in both their personal and professional lives. Throughout the podcast, Paul provides suggestions and advice to those interested in the field of psychology and those wanting to start their own practice. He is still fascinated with the brain and how it works and how the two hemispheres work and communicate with each other that he says a good therapist is “an amygdala whisperer.” Listen to the podcast for other advice and to find out what challenges are unique to his D.C. clients. Connect with Paul Sheesley: LinkedIn | Facebook | WebsiteConnect with the Show: Twitter | Facebook | LinkedIn https://vimeo.com/686592507 Interests and Specializations Paul Sheesley focuses on working with individuals, couples, and families and uses psychodynamic, emotionally-focused, cognitive behavioral theories and approaches to help people achieve balance in their personal and professional lives. His clinical work also draws on schema therapy and a variety of targeted and thoughtful interventions. Education Bachelor of Science (B.S.), Psychology/Neuroscience (2006); McDaniel College, Westminster, MD.Master of Arts (M.A.), Forensic Psychology (2010); The Chicago School of Professional Psychology, Chicago, IL.Certificate of Advanced Study in Counseling/Clinical Psychology (2013); Towson University, Towson, MD.Certified Schema Therapist (2019): The Cognitive Therapy Institute of New Jersey, Lakewood, NJ. Other Sources and Links of Interest Paul Sheesley at PsychologyTodaySchema Therapy Training Institute Podcast Transcription 00:00:13 BradleyWelcome to the Master's in Psychology podcast where psychology students can learn from psychologists, educators, and practitioners to better understand what they do, how they got there, and hear the advice they have for those interested in getting a graduate degree in psychology. I'm your host, Brad Schumacher, and today we welcome Paul Sheesley to the show.

Podcast #280: A Beloved and Brilliant Voice from the Past: Dr. Stirling Moorey! Rhonda and I are thrilled to welcome Dr. Stirling Moorey, from London, England, to today's podcast. Stirling was one of my first students, and he sat in with me my on all my sessions as a co-therapist for a month for two summers in the late 1970s. I wrote about Stirling in my first book, Feeling Good: The New Mood Therapy, which was published in 1980. One of the miracles of the internet, and zoom, is the chance to reunite with friends and colleagues from the past. Needless to say, Rhonda and I were SO EXCITED when Stirling accepted the invitation to join us! Rhonda starts the podcast by saying that “Dr. Stirling Moorey had the good fortune to be trained and supervised by two pioneers in the field of cognitive therapy, Drs. Aaron Beck and David Burns. In 1979, when Stirling was still in medical school in London, he did an elective with Dr. Aaron Beck at the Centre for Cognitive Therapy in Philadelphia.“ I (David) might put it a bit differently. I would say that during the early days of cognitive therapy, I had the fantastic opportunity to do co-therapy together with Stirling with many patients. I learned a tremendous amount from Stirling, even though I was, in theory, the “expert” and he, in theory, was a totally untrained and green novice. But he was phenomenal right out of the gates, and those months were among the happiest of my life. What I learned by observing Stirling's superb interactions with my patients eventually morphed into my Five Secrets of Effective Communication and my first book, Feeling Good Together! Rhonda continues: "Stirling was one of the first British therapists to study CBT when that discipline was in its infancy. David described their fantastic collaborative work with Stirling in Feeling Good, and has described Stirling's brilliant empathy skills in dozens of workshops. Stirling is currently a Consultant Psychiatrist in Cognitive Behaviour Therapy, and was the Professional Head of Psychotherapy for the South London and Maudsley Trust from 2005-2013. He has been a Visiting Senior Lecturer at the Institute of Psychiatry, Psychology & Neuroscience in London." Stirling is a highly regarded therapist, trainer / supervisor / teacher and workshop leader. His main research interest is in the application of CBT to life threatening illness and adversity. He was one of the first therapists to develop CBT for people with cancer and has contributed to five randomized controlled trials in both early and late stage cancer. Stirling is also co-author with Steven Greer of The Oxford Guide to CBT for People with Cancer, and has co-edited a book entitled The Therapeutic Relationship in Cognitive Behavioural Therapy, published by SAGE (Moorey & Lavender, eds.) During today's podcast, Stirling reminds us that one of the aims of cognitive therapy is encouraging patients to examine their distorted negative thoughts and self-defeating beliefs in a way that is not threatening. If patients don't feel validated, they may feel attacked and become defensive, which, of course, can undermine the therapist's effectiveness. He also reminded us that the grandfather of cognitive therapy, the late Dr. Albert Ellis from New York, often attacked the beliefs of his patients in a somewhat aggressive manner, and that this can frequently trigger therapeutic resistance. In fact, an overly aggressive therapeutic style can split patients and colleagues into two camps: those who love you, and those who may stubbornly resist and oppose you. During the podcast, we reminisced a bit on shared memories, and Stirling said that “David took me under his wing with such willingness to share his knowledge and experience . . . and I was just an ordinary medical student. We had many great moments!” Although Stirling was tempted to relocate to America, he decided to remain in England, and has never regretted that decision. For one thing, he met and married his beloved Magda. My own wife, Melanie, and I were honored to take our two kids to England to attend their marriage. We all loved England and had a ball! Magda, Stirling's wife We discussed some of Stirling's amazing work with the patients we saw together in Philadelphia, as well as his visit one summer when we were in California visiting with Melanie's parents in Los Altos, where we now live. Stirling recalled that when we were out shopping one day, my wife and I tried to persuade him to purchase a large Stetson hat, but he resisted! Stirling described the three ways in which he encourages people to change their negative thoughts using the Socratic Technique of gentle questioning: he  asks if the negative thoughts are realistic, if they are helpful, and if an alternative perspective can be taken. The reality testing approach focuses on the important differences between healthy negative feelings, like healthy sadness or grief, which don't usually need any treatment, and unhealthy negative feelings like depression, or a panic attack. One key difference is that healthy negative feelings always result from valid, undistorted thoughts. For example, if a loved one dies, you may tell yourself, “I still love him with all my heart, and I'll miss the many wonderful times we spent together.” In contrast, unhealthy negative feelings result from negative thoughts about the person who died that are distorted. For example, a young woman who's brother committed suicide told herself, “It's my fault he was depressed because our parents love me more when we were growing up. I should have know that he was considering suicide the day he died, so I, too, deserve to die.” Of course, the distorted thoughts don't have to result from a traumatic event. For example, a chronically depressed patient may tell himself, “I'm a loser, and I'll be depressed forever.” A more pragmatic treatment approach focuses less on whether thoughts are distorted or not, but rather on their effects. It's possible for a thought to be realistic but unhelpful. If a tightrope walker in the circus thinks during their act, ”If I fall I will die,” this may be realistic but not very helpful! Stirling talked about how the third way to look at changing thoughts is based on the fact that our lives always have a narrative—a story we tell ourselves about what has happened, or what is happening right now in our lives. These stories can have a powerful impact on how we all think, feel, and behave, and may often function as self-fulfilling prophecies. We can change these stories to make them more adaptive for us. For instance, rather than seeing the glass as half empty, we can see it as both half empty and half full; or we may choose to focus on what you can control vs. what you can't. What I've written so far are just some general ideas, summaries of things that we talked about on the podcast. But when you listen to the podcast, you will perhaps notice the warmth, richness, and depth in the way Stirling thinks and communicates. Then you will “see” and experience his true genius and his immense compassion! We hope that we can entice Stirling to present to one of our free weekly training groups, and perhaps even see if he might agree to do another co-therapy sessions with me that we can publish on a podcast, so you can actually see and experience this master therapist in action! Rhonda, Stirling and David

Today we sit down with someone I've been trying to get on the show for the better part of a year. You might know him on Instagram as The HVAC Doctor. The great Dr Matt Waxer joins us today to talk all about his journey into the trades. Starting off living the typical narrative in high school, Matt had an interest in the trades, but listened to those who told him he had a brighter future going to university. So, that what he did. For 13 years. To become a doctor. Literally, he has a PhD in Psychology & Neuroscience. But, after a change in the retirement structure for instructors, he decided to change this up and followed his passion of working with his hands straight back to the trades where he now works as a gasfitter and Red Seal HVAC/R technician. Listen in to hear Matts incredible story of how and why he went the academic route for 13 years, got his PhD, only to find his true success and happiness helping people stay cool! Don't forget to subscribe to this channel, and on our website blueisthenewwhite.com to receive all the latest updates. As always, this show is not monetized & we don't run ads. We rely strictly on the word of mouth from our listeners to further the mission. So if you enjoyed this episode, please take a moment to rate, review, and share. The future generations of tradespeople depend on it. On you! So thank you again and enjoy this episode of Blue is the New White with The HVAC Doctor, Matt Waxer

Being in the zone is called a flow state in Psychology/Neuroscience, it is the state of focusing on one task to the point that information from the outside world can not even reach our conscious awareness. Team Flow is the very specific circumstance where we are in the zone or in a state of flow but we can specifically not ignore our teammates and integrate the information from other people while keeping that high level of focus. We also learn how professional video gamers are a perfect population for testing this phenomenon which is only a new field to academic study.

In Episode 26, Lance continues the Psychology/Neuroscience mini-series of the podcast with Cliff of Psychological Tactics. Cliff is an Army veteran and an active Law Enforcement Officer who has been developing educational material to help law enforcement and first responders gain psychological preparedness for the hazards of the job through his company the Human Performance and Readiness Institute.

In this episode of THE ARTISTS podcast we have Veena D Dwivedi-a professor in Psychology/Neuroscience and PhD in Linguistics. Find her at: https://brocku.ca/dwivedi-brain-and-language-lab/ Main pointers for the talk: 1) Does the human brain think with language? 2) How will we think if language was not there? 3) What kind of signals the brain develops in terms of the thinking process? 4) If we talk in one language, and think in another will that affect our perception of the world? 5) Is our perception guided by language? 6) Does being bilingual/ Multilingual help creativity? Enjoy!!! Email id: metaphysicallab@gmail.com/  You can follow us and leave us feedback on Facebook, Instagram, and Twitter @eplogmedia, For partnerships/queries send you can send us an email at bonjour@eplog.media   Image credits: © La Biennale di Venezia/Foto ASAC/Andrea Avezzù Intro Music: "Hard Boiled" by Kevin MacLeod (https://incompetech.com) License: CC BY (http://creativecommons.org/licenses/by/4.0/ Outro Music: Shades of Spring by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/4342-shades-of-spring License: https://filmmusic.io/standard-license   DISCLAIMER: The views expressed on all the shows produced and distributed by Ep.Log Media are personal to the host and the guest of the shows respectively and with no intention to harm the sentiments of any individual/organization. The user acknowledges and agrees that Ep.Log Media shall not in any manner whatsoever be responsible or liable for the content. The said content is not obscene or blasphemous or defamatory of any event and/or person deceased or alive or in contempt of court or breach of contract or breach of privilege, or in violation of any provisions of the statute, nor hurt the sentiments of any religious groups/ person/government/non-government authorities and/or breach or be against any declared public policy of any nation or state. See omnystudio.com/listener for privacy information.

Dr Gerard Drennan Ph.D. is a Consultant Clinical Psychologist and Psychoanalytic Psychotherapist, who holds the post of Head of Psychology & Psychotherapy in the Behavioural & Developmental Psychiatric Operational Directorate of the South London & Maudsley Mental Health Foundation Trust. He is also an Honorary Lecturer at the Institute of Psychiatry, Psychology & Neuroscience at Kings College London.Gerard qualified as a clinical psychologist in Cape Town.His doctoral research examined the practical and political role of language and interpreters in mental health practice in post-colonial, institutional settings.This research ran concurrently with the work of South African Truth and Reconciliation and was touched, as all South Africans were, by the restorative aspirations of that nation-building endeavour.Gerard has held clinical and leadership roles in forensic and offender mental health settings in London and Sussex for the past 20 years. This included a leadership role in developing the Millfield Unit, part of the Personality Disorder and DSPD project. He has published on the implementation of recovery-oriented practice and, since training in restorative justice conferencing in 2012, has worked and written on the place of restorative justice practices in mental health settings.

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy. Meta-analysis finds dietary supplements improve sleep quality Hong Kong Polytechnic University, January 27 2021.    A systematic review and meta-analysis published on January 13, 2021 in Postgraduate Medical Journal found benefits for supplemental vitamin D, melatonin and amino acids in improving the quality of sleep among men and women.  The meta-analysis included 15 randomized, controlled trials that examined the association between subjective sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) and supplementation with amino acids, the hormone melatonin, omega 3 fatty acids and vitamin D. Pooled data for the two studies involving amino acid supplements, seven studies involving melatonin, and four studies involving vitamin D each showed significant differences between supplemented and control groups, with more favorable PSQI scores occurring among those who received the supplements. The two studies that evaluated omega 3 did not reveal significant differences between the treatment and control groups. Two reviewed trials that were not eligible for inclusion in the meta-analysis added evidence to the benefit of melatonin in sleep quality. Other non-included trials found a benefit for nitrate-containing beetroot juice, resveratrol and zinc supplements. Co-supplementation with melatonin, magnesium and zinc was also associated with a significant benefit in comparison with a placebo.  “Although we found a significant improvement in sleep quality by dietary supplementation, randomized, controlled trials with longer duration and larger sample size should be conducted to verify our findings,” noted authors Vicky Chan and Kenneth Lo of The Hong Kong Polytechnic University. “Furthermore, dose–response effect of different supplements on sleep quality has not yet been evaluated.” “Amino acids, vitamin D and melatonin supplements were significantly beneficial to improve sleep quality,” they concluded. “Further research on the effect of magnesium, zinc, resveratrol and nitrate supplementation on improving sleep quality is required.”     Green coffee extract and silymarin protect against carbon tetrachloride-induced liver toxicity University of Tabuk (Saudi Arabia), January 26, 2021   According to news originating from the University of Tabuk research stated, “During the last few decades, patients worldwide have been interested in using alternative medicine in treating diseases to avoid the increased side effects of chemical medications. Green coffee is unroasted coffee seeds that have higher amounts of chlorogenic acid compared to roasted coffee.” Our news journalists obtained a quote from the research from University of Tabuk: “Green coffee was successfully used to protect against obesity, Alzheimer disease, high blood pressure and bacterial infection. This study aimed to investigate the probable protective activity of the green coffee methanolic extract, silymarin and their combination on CCl4-induced liver toxicity in male rats. Thirty Sprague - Dawley male albino rats were divided into 5 groups; control negative (G1) just got the vehicle (olive oil) and the other four groups received CCl4 dissolved in olive oil through an intraperitoneal injection and were divided into untreated control positive group (G2), the third group (G3) was treated with green coffee methanolic extract, the fourth group (G4) was treated with silymarin, and the fifth group (G5) was treated with a combination of green coffee methanolic extract and silymarin. In the positive control group treated with CCl4 (G2), the CCl4-induced toxicity increased lipid peroxidation, IL-6, kidney function parameters, liver function enzymes, total cholesterol, triglycerides and low-density lipoproteins, and decreased irisin, antioxidants, CYP450 and high-density lipoprotein levels. Hepatic tissues were also injured. However, treating the injured rats in G3, G4 and G5 significantly improved the altered parameters and hepatic tissues.” According to the news reporters, the research concluded: “Green coffee methanolic extract, silymarin, and their combination succeeded in protecting the male rats against CCl4 hepatotoxicity due to their antioxidant activity. Effect of green coffee methanolic extract mixed with silymarin in G5 was more efficient than that of green coffee methanolic extract in G3 or silymarin in G4.”     Vitamin D status and outcomes for hospitalised older patients with COVID-19 NHS Foundation Trust and University of Cyprus, January 21, 2021   Purpose Older adults are more likely to be vitamin D deficient. The aim of the study was to determine whether these patients have worse outcomes with COVID-19. Methods We conducted a prospective cohort study between 1 March and 30 April 2020 to assess the importance of vitamin D deficiency in older patients with COVID-19. The cohort consisted of patients aged ≥65 years presenting with symptoms consistent with COVID-19 (n=105). All patients were tested for serum 25-hydroxyvitamin D (25(OH)D) levels during acute illness. Diagnosis of COVID-19 was confirmed via viral reverse transcriptase PCR swab or supporting radiological evidence. COVID-19-positive arm (n=70) was sub-divided into vitamin D-deficient (≤30 nmol/L) (n=39) and -replete groups (n=35). Subgroups were assessed for disease severity using biochemical, radiological and clinical markers. Primary outcome was in-hospital mortality. Secondary outcomes were laboratory features of cytokine storm, thoracic imaging changes and requirement of non-invasive ventilation (NIV). Results COVID-19-positive arm demonstrated lower median serum 25(OH)D level of 27 nmol/L (IQR=20–47 nmol/L) compared with COVID-19-negative arm, with median level of 52 nmol/L (IQR=31.5–71.5 nmol/L) (p value=0.0008). Among patients with vitamin D deficiency, there was higher peak D-dimer level (1914.00 μgFEU/L vs 1268.00 μgFEU/L) (p=0.034) and higher incidence of NIV support and high dependency unit admission (30.77% vs 9.68%) (p=0.042). No increased mortality was observed between groups. Conclusion Older adults with vitamin D deficiency and COVID-19 may demonstrate worse morbidity outcomes. Vitamin D status may be a useful prognosticator.   Mental Disorders Forecast Chronic Physical Diseases, Premature Death University of Michigan, January 22, 2021 Poor early-life mental health may jeopardize later-life physical health, according to a new study led by a University of Michigan researcher. The study, published in the journal JAMA Network Open, indicates that people who experience psychiatric conditions when they are young are likely to experience excess age-related physical diseases when they are older. Leah Richmond-Rakerd, U-M assistant professor of psychology, and colleagues found that this association cannot be explained by preexisting physical illness; they ruled out the possibility of reverse causation in which having a physical illness precipitates mental health problems. Prior studies had not taken this into account. This association is present across different mental disorders and different physical diseases, she said. The researchers conducted a nationwide hospital-register study of 2.3 million New Zealanders—aged 10-60 years at baseline—followed across three decades (1988 to 2018). They tested whether individuals with mental disorders are at increased risk for subsequent chronic physical diseases and premature mortality. Richmond-Rakerd and colleagues collected information about hospital admissions for different mental disorders, such as substance use disorders, psychotic disorders, mood disorders, anxiety disorders and self-harm behavior. In addition, researchers collected information about hospital admissions for different chronic physical diseases, ranging from coronary heart disease to cancer. Across the 30-year period, individuals with mental disorders were more likely to develop subsequent physical diseases and they also died earlier than people without mental disorders, the study showed. They also experienced more medical hospitalizations, spent more time in hospitals for physical-disease treatment and accumulated more associated health care costs. These associations were present across all age groups and in both men and women. The findings indicate that addressing mental health problems in early life might be a window of opportunity for preventing future physical diseases, Richmond-Rakerd said. They also suggest the importance of joined-up services, or integrated care. “Our health care system often divides treatment between the brain and the body,” she said. “Integrating the two could benefit population health.” Richmond-Rakerd said they chose New Zealand because there it is possible to link hospital registers and other administrative databases for the entire population of the country. The study’s co-authors are Stephanie D’Souza and Barry Milne of the University of Auckland, Avshalom Caspi and Terrie Moffitt of Duke University and King’s College London.   'Aging well' greatly affected by hopes and fears for later life, study finds Oregon State University, January 21, 2021   If you believe you are capable of becoming the healthy, engaged person you want to be in old age, you are much more likely to experience that outcome, a recent Oregon State University study shows. "How we think about who we're going to be in old age is very predictive of exactly how we will be," said Shelbie Turner, a doctoral student in OSU's College of Public Health and Human Sciences and co-author on the study. Previous studies on aging have found that how people thought about themselves at age 50 predicted a wide range of future health outcomes up to 40 years later -- cardiovascular events, memory, balance, will to live, hospitalizations; even mortality.  "Previous research has shown that people who have positive views of aging at 50 live 7.5 years longer, on average, than people who don't," said Karen Hooker, co-author of the study and the Jo Anne Leonard Petersen Endowed Chair in Gerontology and Family Studies at OSU.  Because self-perceptions of aging are linked to so many major health outcomes, Hooker and Turner wanted to understand what influences those perceptions. Their study looked specifically at the influence of two factors: self-efficacy associated with possible selves, meaning a person's perceived ability to become the person they want to be in the future; and optimism as a general personality trait.  The researchers measured self-perception of aging by having respondents say how strongly they agreed or disagreed with statements such as, "Things keep getting worse as I get older," "I have as much pep as I had last year," "As you get older, you are less useful." They measured optimism in a similar way, with respondents ranking their agreement with statements like "In uncertain times I usually expect the best."  To measure self-efficacy, the study used a dataset that compiled survey responses from older adults where they listed two "hoped-for" future selves and two "feared" future selves, and ranked how capable they felt of becoming the person they hoped to be and avoiding becoming the person they feared to be.  Among the "hoped for" selves were things like "A social person with a strong network of friends" and "A healthy, active person." Examples of "feared" selves were "Chronically sick and in pain," "Being dependent on others for my day-to-day needs" and "A cranky, angry old woman."  Results showed that, as predicted, higher optimism was associated with more positive self-perception of aging. Both "hoped-for" self-efficacy and "feared" self-efficacy were also significantly associated with self-perception of aging, above and beyond optimism as a trait.  A major factor in how people see their own aging selves is internalizing ageist stereotypes, the researchers said. Examples of such stereotypes include assumptions that older adults are bad drivers, or suffer memory problems, or are unable to engage in physical activity anymore.  "Kids as young as 4 years old already have negative stereotypes about old people," Hooker said. "Then, of course, if you're lucky enough to live to old age, they eventually apply to you."  Those stereotypes get reinforced every time an older adult forgets something and jokes, "Another senior moment!" But the researchers say these thought patterns can do real harm. "People need to realize that some of the negative health consequences in later life might not be biologically driven. The mind and the body are all interwoven," Hooker said. "If you believe these bad things are going to happen, over time that can erode people's willingness or maybe even eventually their ability to engage in those health behaviors that are going to keep them as healthy as they can be."  A way to mitigate those negative stereotypes about aging is to promote intergenerational relationships, so younger people can see older adults enjoying happy, healthy lives.  "The more you're around older people, the more you realize that it's not all bad," Turner said. "Older people can do some things better than young people do. Increasing opportunities for intergenerational relationships is one way we can make people more optimistic about aging."   Over half of cannabis users with Parkinson's disease report clinical benefits University Medical Center Hamburg-Eppendorf (Germany), January 26, 2021   With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD). According to results of a survey of PD patients in Germany in the Journal of Parkinson's Disease, over 8% of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect. Cannabis products containing THC (tetrahydrocannabinol, the main psychoactive compound of cannabis) can be prescribed in Germany when previous therapies are unsuccessful or not tolerated, and where cannabis can be expected with not a very unlikely chance to relieve disabling symptoms. CBD (pure cannabidiol, derived directly from the hemp plant, a cousin of the marijuana plant) is available without a prescription from pharmacies and on the internet. "Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data," explained lead investigator Prof. Dr. med. Carsten Buhmann, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. "PD patients fulfilling these criteria are entitled to be prescribed medical cannabis, but there are few data about which type of cannabinoid and which route of administration might be promising for which PD patient and which symptoms. We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result." Investigators aimed to assess patient perceptions of medicinal cannabis as well as evaluate the experiences of patients already using cannabis products. They performed a nationwide, cross-sectional, questionnaire-based survey among members of the German Parkinson Association (Deutsche Parkinson Vereinigung e.V.), which is the largest consortium of PD patients in German-speaking countries with nearly 21,000 members. Questionnaires were sent out in April 2019 with the association's membership journal and were also distributed in the investigators' clinic. Over 1,300 questionnaires were analyzed; results showed that interest in the PD community in medical cannabis was high, but knowledge about different types of products was limited. Fifty-one percent of respondents were aware of the legality of medicinal cannabis, and 28% were aware of the various routes of administration (inhaling versus oral administration), but only 9% were aware of the difference between THC and CBD.  More than 8% of patients were already using cannabinoids and more than half of these users (54%) reported that it had a beneficial clinical effect. The overall tolerability was good. Over 40% of users reported that it helped manage pain and muscle cramps, and more than 20% of users reported a reduction of stiffness (akinesia), freezing, tremor, depression, anxiety, and restless legs. Patients reported that inhaled cannabis products containing THC were more efficient in treating stiffness than oral products containing CBD but were slightly less well tolerated.  Patients using cannabis tended to be younger, living in large cities, and more aware of the legal and clinical aspects of medicinal cannabis. Sixty-five percent of non-users were interested in using medicinal cannabis, but lack of knowledge and fear of side effects were reported as main reasons for not trying it.  "Our data confirm that PD patients have a high interest in treatment with medicinal cannabis but lacked knowledge about how to take it and especially the differences between the two main cannabinoids, THC and CBD," noted Prof. Dr. med. Buhmann. "Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis. The data reported here may help physicians decide which patients could benefit, which symptoms could be addressed, and which type of cannabinoid and route of administration might be suitable." "Cannabis intake might be related to a placebo effect because of high patient expectations and conditioning, but even that can be considered as a therapeutic effect. It has to be stressed, though, that our findings are based on subjective patient reports and that clinically appropriate studies are urgently needed," he concluded.  Bastiaan R. Bloem, MD, PhD, Director, Radboudumc Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands, and Co-Editor-in Chief of the Journal of Parkinson's Disease, added: "These findings are interesting in that they confirm a widespread interest among patients in the use of cannabis as a potential treatment for people living with PD. It is important to emphasize that more research is needed before cannabis can be prescribed as a treatment, and that guidelines currently recommend against the use of cannabis, even as self-medication, because the efficacy is not well established, and because there are safety concerns (adverse effects include among others sedation and hallucinations). As such, the present paper mainly serves to emphasize the need for carefully controlled clinical trials to further establish both the efficacy and safety of cannabis treatment."   Covid lockdown loneliness linked to more depressive symptoms in older adults University of Exeter (UK), January 22, 2021   Loneliness in adults aged 50 and over during the COVID-19 lockdown was linked to worsening depressive and other mental health symptoms, according to a large-scale online study.  Loneliness emerged as a key factor linked to worsening symptoms of depression and anxiety in a study of more than 3,000 people aged 50 or over led by the University of Exeter and King's College London, and funded by The National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC) .  Researchers had access to data going back to 2015 for participants of the PROTECT online study. They also found that a decrease in physical activity since the start of the pandemic was associated with worsening symptoms of depression and anxiety during the pandemic. Other factors included being female and being retired.  Dr Byron Creese, of the University of Exeter Medical School, who led the study, said: "Even before the pandemic, loneliness and physical activity levels were a huge issue in society, particularly among older people. Our study enabled us to compare mental health symptoms before and after COVID-19 in a large group of people aged 50 and over. We found that during lockdown, loneliness and decreased physical activity were associated with more symptoms of poor mental health, especially depression. It's now crucial that we build on this data to find new ways to mitigate risk of worsening mental health during the pandemic." The study found that before the pandemic, lonely people would report an average of two symptoms of depression for at least several days over the previous last two weeks. During lockdown, lonely people reported either an increase in frequency of depressive symptoms, to more than half the days in the two week period, or a new symptom for at least several days in that timeframe. In people who were not lonely, levels of depressive symptoms were unaffected.  PROTECT began in 2011, and has 25,000 participants signed up. Designed to understand the factors involved in healthy ageing, the innovative study combines detailed lifestyle questionnaires with cognitive tests that assess aspects of brain function including memory, judgment and reasoning over time. In May, researchers included a new questionnaire designed to assess the impact of COVID-19 on health and wellbeing. Running from May 13 to June 8, the questionnaire was completed by 3,300 people, of which 1,900 were long-standing PROTECT participants. The study is continuing to run so that longer term outcomes can be assessed.  Zunera Khan, Research Portfolio Lead at Institute of Psychiatry, Psychology & Neuroscience said "We've found links between loneliness and a drop in physical exercise and worsening mental health symptoms. It should be within our power to find ways of keeping people socially engaged and active. Our online PROTECT platform ultimately aims to find new ways to engage people in their homes, however, technology can only be part of the picture. We need to ensure we can find new ways to help people stay active and social, whether they are online or not." Professor Clive Ballard, Executive Dean and Pro-Vice Chancellor of the University of Exeter Medical School, who leads PROTECT, said: "We are only just beginning to learn the impact that COVID-19 is having on the health and wellbeing of older people. For example, the effect of any economic impact may not yet have emerged. Our large scale study will span a number of years, and will help us understand some of the longer-term effects of COVID-19 on mental health and wellbeing, and ultimately, on whether this has any knock-on effect on aspects of ageing, such as brain function and memory. " The study plans to conduct further analysis on groups at particularly high risk, such as people with cognitive impairment and those with caring rolesG

Min Kwon is a Sr. Marketing Analyst at PepsiCo Beverages NY. He is part of the Water portfolio, leading the digital strategy and societal purpose on LIFEWTR's brand communication team. He is also involved with the PepsiCo Asian Network, the LGBTQ+ ERG EQUAL, and The League. On the side, he also hosts his own podcast, UPWARD, which highlights Asian Americans in corporate America and their journeys and advice as they have learned throughout their career. He graduated from Yale University with a BA in Psychology Neuroscience.

In this episode of the podcast, I have a special guest with me Dipanjan Das, a scientist and virtual reality development researcher working on the parameters of Virtual Reality and how it will affect our futures. We dive into the topic of VR and I break down his research. We talk about the problems with VR, parameters of optimization, future technologies, and much, much, more. @ 0:00 Introduction: Dipanjan Daas -- Ph.D. Virtual Reality Development @ 0:27 A Research on Human Vision: Visualizations and Augmented Reality @ 1:15 Current Problems with VR: Optimizing Headset Parameters @ 2:40 Parameters of Virtual Reality -- Resolutions, Field of View Design and Quality of Experience @ 3:54 Limits Of Human Biology: Maximum Visual Resolutions & Refresh Rates @ 4:40 Usage & Comfortability: Nausea, Flicker Rates, and Field of View @ 7:03 VR , AR , MR , and XR Technologies: The Future of Virtual Realities @ 8:11 The XR Umbrella, Extended Reality and The Umbrella of Augmentation @ 10:34 The Virtual Reality Project: Designing the Minimum Requirements @ 12:25 Modelling the Human Eye and Biological Limitations @ 15:10 Virtual Reality as A Business: Big Names in The Industry @ 16:02 Applications of Virtual Reality: Stand Alone Devices, Haptic Technology, and The Future of Smartphones @ 17:42 Remote Applications of VR: Remote Training and Learning @ 18:46 Technologies Involved with VR: Integrating the Web of Technology @ 20:10 Integration of VR -- Haptics and Feedback Pasteables: Interacting With a Virtual World @ 25:40 Understanding the Psychology: Neuroscience, Virtual Worlds and the Psychological Effects of Augmented Perceptions @ 29:03 Commercialization: Emerging Technologies, Bringing Tech to The Consumer @ 29:54 Background and Motivation: The Route to Becoming a VR Developer and Researcher @ 34:38 Integrating Intelligence: Creating a Network of Supertechnologies, Artificial Intelligence, Superintelligence @ 35:55 Biotechnology and Embedding of Technology into The Human Body: Will Virtual Reality Become the New Reality? @ 37:24 A Moral Dilemma -- Privacy Concerns, Issues with Monitoring and Data Collection @ 39:49 Project: End Goals and Motives -- What This Research Will Bring Forward @ 41:11 The Future of VR Technology -- A More In-depth Talk, and Final Conclusions

The benefits of journaling: Episode Notes Journaling is a practice that has been proven to be very effective for both our body and our mind. In fact, according to a few authoritative studies, expressive writing (which includes journaling) can lower blood pressure, improve immune system functionality and positively affect our mood, among other things.In this episode of the Stepsero podcast we host Amánda Efthimiou, Mental Health Advocate, Writer, and Entrepreneur, to discuss different approaches to journaling, including poetry.Here are some highlights from our discussion: According to Dr. Jill Bolte Taylor, the chemical processes that are provoked by our emotions end within 90 seconds. Everything that happens after that is the result of the stories that you tell yourself. Based on this, journaling could help label your emotions, and ultimately allow you to regulate and balance your feelings.A gratitude journal can be a great way to start, and it can be as simple as writing three things that you are grateful for in the morning.Writing in free flow for just 15-20 minutes can be a very liberating act, even if you don't read again what has been written. This is not limited to only creative writers, but rather to anyone who wants to experiment with different forms of writing and journaling.Bullet-points can also be useful, especially when compiling a list of things you want to get done on a specific day, as well as the feeling you want to have by the time you go to sleep.Companies can also benefit from bullet journaling, as their employees can use this method to prioritize their goals and plan their week better.For Amanda, poetry is a great way to interpret her thoughts and give them a special meaning. Given its peculiar form, poetry allows her to express herself in a more articulated way compared to more traditional forms of journaling. Our Guest: Amanda Efthimiou Amanda Efthimiou is a mental health advocate, writer, and community creator. She founded I.ÁM with a mission to help people design their lives around caring for their mental health. As part of her passion for nurturing communities through experiences, she’s now built a network of women around the world who use I.ÁM’s core principles to refocus conversations on women’s healing, psychedlic therapy and integration. She also uses poetry and creative fiction as an artistic practice to highlight the shared human experiences of our inner states and to spark conversations about mental health. Her writing has been published in online publications such as The Mighty and Designing the Next Decade, and her poetry was recently featured in a Lisbon-based art exhibition. She’s currently also pursuing her MSc in Psychology & Neuroscience of Mental Health at King’s College, London.References:Amanda Efthimiou Linkedin profileAmanda's WebsiteAmanda's Blog (Medium) Listen to the next Episode All Podcast Episodes

Miriam shares her mental health journey. She talks about how her depression led to an eating disorder; alcohol abuse; and a suicide attempt. Miriam is completing her masters now in Psychology & Neuroscience of Mental Health and has started a project called “all in our head” which is a collection on stories on mental illness from members of the public. Find here: allinourhead.com Follow here: @all_inourhead

Thank you for listening to episode 15 of The Classic Manny Show, hosted by yours truly. I am joined by the multifaceted babe Sharon Rose – who is currently studying Psychology & Neuroscience and is also a renowned Chef, MUA and Graphic Designer. Make sure to subscribe, rate the podcast and use #TCMSHOW to join the conversation.   DISCUSSION; In today's episode, we remove our favourite segments in order to go in-depth into how our upbringing impacts our adulthood, using myself as the focus. With Sharon's guidance and knowledge, I share my experience with having an absent father, being raised by a single mother and how those experiences impacted me as a child until now.     FOLLOW SHARON ROSE ON SOCIAL MEDIA: Twitter – https://twitter.com/SharonnRosee Instagram – https://www.instagram.com/srnrose_   FOLLOW ME ON SOCIAL MEDIA @THECLASSICMANNY / @TCMANNYHQ: Twitter – https://twitter.com/THECLASSICMANNY https://twitter.com/tcmannyhq Instagram – https://www.instagram.com/theclassicmanny https://www.instagram.com/tcmannyhq/   For enquires – theclassicmanny@yahoo.com To send questions, dilemmas or inspiring stories - https://curiouscat.me/TCMANNYHQ

By request! This episode is a crash course in the psychology of a compelling vibe. What's going on in the brain when your future clients tune into your corner of the internet? What's going on in YOUR brain when you tune into an influencer you love? One hour from now, these will no longer be mysterious forces ;) You'll have the inside scoop as to what's going on the brain when you're picking up + putting out good vibes Know you wanna learn the tactics + strategies to actually IMPLEMENT on all of this in your business? JOIN BTAB, I teach you all the ninja tricks in there ;) Here's the link to binge all the details + apply: https://www.carolineaddington.com/BTAB Did this episode blow your mind?? SHARE IT, BOO! :) Share it in your IG stories + tag me @caroline.addington_ I love getting to see you guys enjoying the episodes! Inside this episode~ - the episode about the psychology of decision making triggers [ it's the BECOME A LAUNCH NINJA episode ;) ] - what even IS a vibe psychologically?! and also some fun facts on why you feel good vibes in certain PHYSICAL spaces too - why is this important in your marketing + your online presence? - the neuroscience of emotional decision making - how emotions are actually made and why it's not what we used to think back in the day - how to use all this info in your personal growth journey as well to rocket boost your growth

Opinions on the accuracy of Net Promoter Score (NPS) as a customer loyalty measure vary widely. But like it or not, the reality is that a lot of organizations use NPS. It has become a standard key performance indicator (KPI) that many business executives embrace. So it's not going away anytime soon. The question for those of us who care about data accuracy, is how can we augment or possibly modify it to make sure that the data story told by NPS, is going to help the business improve. Many people think they “know” NPS, but once you dive in and actually start working with it, you find there is more to making it useful than simply counting “promotors” versus “detractors.” A lot more. In this excerpt from a guest lecture delivered to Research Rockstar students, NPS expert Paul Abel tackles burning questions about controversies surrounding NPS (is it a truly useful measure of loyalty?), and his experience in optimizing research programs that use NPS. About the Speaker: For over 25 years, Paul Abel has led qualitative and quantitative research across a wide variety of topics and markets worldwide via his work at Blue Research, and previous work at Intel and Gartner Consulting. Paul holds a PhD in Psychology/Neuroscience from the University of Washington and BS degree from UCLA. Check out his other content and services here: www.blue-research.com  Further NPS-related info: A video chat on NPS with Kathryn Korostoff and guest Jeffrey Henning of Researchscape. Two well-done articles on the pitfalls of NPS: this one cites a lot of very credible research and proof points, and this one has research-supported advice on how to improve NPS (access to the full article requires being a subscriber to Quirk’s, and subscriptions are free).

An expert in cognitive neuroscience, Howard recently published his book I Think Therefore I Am Wrong which looks at the many ways we can sabotage our thinking through cognitive biases, binary thought, false assumptions and numerous other strategies. He is also the presenter of the How Not To Think podcast, in which examines how this false reasoning manifests itself in many areas of society through myths, and 'conventional wisdom.' His knowledge of psychology has allowed him to become well established in consulting, speaking and writing about health, wellness, neuroscience. Contacting Howard: Email: drhrankin@gmail.com  Website: Drhowardjrankin.com  KET QUOTES AND TAKEAWAYS FROM THE SHOW:  “I've made a good living for myself thinking two or three times a week.” “All models are wrong, some are useful.” “Prediction is easy unless it's about the future.” QUESTION OF THE DAY (#QOTD): “Can cognitive biases be passed on through your DNA?” For details of the discussion, links to people and resources mentioned, time stamped show notes and #QOTD go to: https://www.myhomevitality.com/howard-rankin-ph-d-psychology-neuroscience-ai-and-how-not-to-think For the video version:  https://bit.ly/2n2M4ay To ask questions of future guests: https://www.facebook.com/myhomevitality CONNECT WITH US:  Website: https://www.myhomevitality.com/  Email: info@myhomevitality.com  Instagram: https://www.instagram.com/myhomevitality/  Twitter: https://twitter.com/myhomevitality  Facebook: https://www.facebook.com/myhomevitality  iTunes Podcast: https://apple.co/2LSGK7J  Soundcloud Podcast: https://soundcloud.com/user-460351592  Stitcher Podcast: https://bit.ly/2KmvYBC  TuneIn Podcast: https://bit.ly/2vcAWfA  Spotify Podcast: https://spoti.fi/3dKfRwK  Overcast Podcast: https://bit.ly/3cvENbc  

Geraldine Dawson is the William Cleland Distinguished Professor of Psychiatry and Behavioral Sciences at Duke University, where she also is Professor of Pediatrics and Psychology & Neuroscience. Dawson is the Director of the Duke Institute for Brain Sciences whose mission is to promote interdisciplinary brain science and translate discoveries into solutions for health and society.  Dawson also is Director of the Duke Center for Autism and Brain Development, an NIH Autism Center of Excellence, which is an interdisciplinary research program and clinic, aimed to improve the lives of those with autism through research, education, clinical services, and policy. She has published several books on autism, including An Early Start for Your Child with Autism, A Parent's Guide to High-Functioning Autism, and  What Science Tells Us about Autism Spectrum Disorder.  Dawson's pioneering studies were among the first to describe the emergence of autism symptoms during infancy, leading to new screening tools. Dawson co-created the Early Start Denver Model, an early autism intervention shown to improve behavioral outcomes, which has been translated into 17 languages and is used worldwide. Her work showed for the first time that early intervention can normalize aspects of brain activity in children with autism, changing the field's view of brain plasticity in autism, a finding recognized by TIME Magazine as one of the top 10 medical breakthroughs of 2012. A strong advocate for persons with autism, Dawson has testified a number of times before the US Congress in support of major autism legislation and was appointed by the U.S. Secretary for Health and Human Services for two terms to the DHHS IACC. All Autism Talk (allautismtalk.com) is sponsored by LEARN Behavioral (learnbehavioral.com).

The drive and determination, love for his family and to be frank, the badassery of this amazing human has me humbled. Take a listen and you will be too. Double Board Certified in Facial Plastic and Reconstructive Surgery as well as in Otolaryngology/Head and Neck Surgery. He graduated from Princeton University where he earned his Bachelor of Arts degree in Psychology/Neuroscience. He received his Medical Degree from Rush University Medical Center in Chicago, Illinois. He then completed his Internship in General Surgery and his Otolaryngology/Head & Neck Surgery Residency at the Mayo Clinic in Rochester, Minnesota. He then went on to serve as a Fellow in Facial Plastic & Reconstructive Surgery at the University of California at Davis Medical Center. He has dedicated his post-graduate training solely to the practice of facial plastic and reconstructive surgery.

Matthew Berry is on this week to talk about his PhD research on the neuroscience behind acting, specifically Matt is interested in the neurological effects of method acting. We talk a bit about the late great Heath Ledger, along with many other topics such as photography, the psychology of humor, and why is it important to take breaks. Matt's Website You can also reach out to Matt via email if you have further questions, at berryma(at)mcmaster.ca or almamac(at)mcmaster.ca --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/get-learnt/message Support this podcast: https://anchor.fm/get-learnt/support

Shane chats with Associate Processor of MCDB and Psychology & Neuroscience at The University of Colorado Boulder, Zoe Donaldson. How do hormones like Vasopressin and Oxytocin impact social behavior? Can studying Prairie Voles tell us anything about human social behavior? Please visit our sponsorsThe Great Courses www.thegreatcoursesplus.com/hereweare https://Libro.fm is the first audiobook company to make it possible for you to buy audiobooks directly through your local bookstore. Offer code: hereweare for 3 months for the price of one. Outro Music by Rebreather - http://rebreather-ohio.bandcamp.com/album/rebreather-ep-2018 Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode Movistar Riders own Psychologist Sens comes on the show to talk about a bunch of different topics including the SLO and the new big name teams that have entered the league, his background in psychology and neuroscience, how a simple intake of breath can increase neuroplasticity and neurogenesis, personal goals and so much more! If you enjoyed this episode and would like to get incontact with Sens find him at: Twitter - @sensguino If this episode was of value please do let me know and let me know how I can help you, do so at: Twitter - @leaguetalkshow Our first ever filmed version of leaguE talk is this episode and it is live on our youtube!

This week we bring on Rachelle Ho, a PhD Candidate from McMaster University. Rachelle has completed a Master's Degree and a Bachelors Degree from the University of Toronto. We ask Rachelle about neuroscience and fMRI(functional Magnetic Resonance Imaging), psychology, new neurotechnology, concussions and much more! In this episode we tested out an intro and outro - we'd love feedback on them as we develop more. Like the RSearch facebook page and message the page on who we should bring in next! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/get-learnt/message Support this podcast: https://anchor.fm/get-learnt/support

For many people, cancer is now survivable and has become a long term condition, and depression and anxiety are more common in cancer survivors than in the general population. Despite this, 73% of patients don't receive effective psychiatric treatment. Alexandra Pitman, consultant liaison psychiatrist at St George's University Hospitals NHS Foundation Trust, and Andrew Hodgkiss, consultant liaison psychiatrist, at the Institute of Psychiatry, Psychology & Neuroscience join us to dispel some of the concern clinicians may have about the complexities of diagnosing depression in cancer - what is biopsychosocial, what is the organic result of the cancer or treatment - and some of the concern about treatment interactions. Read the two education articles: https://www.bmj.com/content/361/bmj.k1415 https://www.bmj.com/content/361/bmj.k1488

On this episode, Dr. Meaghan Creed, a neuroscientist and good friend of both Leena and Shannon, joins us from Balitmore, Maryland. Meaghan got her HBSc in Psychology & Neuroscience at the University of Toronto, and then got her PhD in Neuroscience also at the University of Toronto. She studies how cocaine re-wires the brain’s reward circuitry, and she developed a new treatment that can reverse how cocaine rewires the brain. She is currently an Assistant Professor at the University of Maryland’s School of Medicine, in the U.S. We talked about her interest in arctic tomatoes and the Canadian seal hunt, 80 hour work weeks, and her work investigating a new hope for the treatment of drug addition.

Today on Burning Issues DR. Mich is Joined by Professor Philip Asherson from the Institute of Psychiatry, Psychology & Neuroscience. At King's College London Professor Philip is the head of The ADHD Genetics Group. This group is a research group within the SGDP whose main aim is to identify the genes involved in ADHD and related behavioural traits, and investigate how such genes work together and with environment to influence behaviour.

Anyone working long hours in a creative industry craves mental stamina and focus. We'd all give anything for the drug Bradley Cooper used to transform himself in the film 'Limitless.' With the recent surge in popularity of smart drugs and nootropics, has the 'Limitless' era finally arrived? In this episode I have an in-depth conversation with Dr. Andrew Hill, a PhD in neuroscience and the lead neuroscientist for the company TruBrain* that manufacturers several different forms of nootropics substances that enhance clarity, focus, memory, and cognitive function. We discuss the difference between smart drugs and nootropics, which are safe and which aren't, how you can enhance the effects of coffee, and which substances are the best bang for your buck when it comes to enhancing the capabilities of your brain. (Hint: None of them begin with '5 Hour Energy') * Use the coupon code 'FITNESS' to get 25% OFF your first order at TruBrain. Topics of Conversation: Andrew’s background and how he got started with truBrain  The research they are doing at truBrain and how to apply it to our everyday lives How brain waves work -- it’s “complicated and chaotic” How to read brain waves (cause they’re measurable) Two of the most common smart drugs: caffeine and nicotine Make sure you are being safe when adopting a cognitive enhancer like caffeine How L-Theanine combined with caffeine can help improve focus What alcohol does to your brain waves Other smart drugs and what they do to brain waves What modafinil is used for (and why it can be dangerous) Andrew’s modafinil scare and who should not take it What acetylcholine does to your brain How nootropics work and how you should take them What is truBrain and how can creative people use it? truBrain has their own coffee! The effects of eating glucose while using nootropics The ingredients in truBrain and how they work The difference between the neurons in the brain and the neurons in the heart The elevator pitch for truBrain More technology = more distractions! Get it under control NOW Useful Links: TruBrain Home FiP Podcast: The Science of ADD and ADHD FiP Podcast: Optimizing Brain Function with Neurofeedback FiP Blog: What is Neurofeedback? Guest Bio: Dr. Hill received his PhD in Cognitive Neuroscience from UCLA in 2012, studying how attention operates in the brain. He is currently lecturing for the Undergraduate Education Initiatives program at UCLA, teaching a course sequence gerontology, and the neuroscience of healthy brain aging. Dr. Hill has published chapters on measuring and modulating human attention, and continues to research self regulation. Prior to UCLA, Dr. Hill obtained extensive experience working with both psychiatric and developmental populations as well as gaining experience in high technology areas. He received his B.S. in Psychology/Neuroscience from UMass Amherst. See Andrew’s book chapters Measuring & Modulating Hemispheric Attention and EEG Correlates of Hemispheric Word Recognition. Show Credits: This episode was edited by Curtis Fritsch, the show notes were prepared by Natalie Boschan, and this show is executive produced by Kanen Flowers. We are a member of the THAT STUDIO podcast network. The music in the opening and closing of the show is courtesy of Dorian Cheah from his brilliant album ARA.

This is Part 2 of my interview with clinical psychologist and researcher Dr Eric Morris. Eric currently works as the Director of the La Trobe University Psychology Clinic. Previously he worked as a consultant clinical psychologist and the psychology lead for early intervention for psychosis, at the South London and Maudsley NHS Foundation Trust, UK. Eric trained as a clinical psychologist in 1994-1995 at Murdoch University, specialising in psychological interventions for psychosis. On qualifying he worked in a pioneering service for early intervention for psychosis in Perth, Western Australia, before moving to the UK in 1999 to work for the National Health Service in Hampshire and South London. His clinical experience is in providing cognitive-behavioural and family interventions for people recovering from serious mental illness (psychosis, bipolar disorder) and their families. Eric has been practising Acceptance and Commitment Therapy (ACT) for 15 years, including supervising and training therapists in this area. He is a founding member and a former chair of the Acceptance and Commitment Therapy Special Interest Group (ACTSIG) of the British Association for Behavioural and Cognitive Psychotherapies. In 2013 Eric completed his PhD at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, researching psychological flexibility and auditory hallucinations. He also researched ACT as a group-based intervention for people recovering from psychosis, and as a workplace resilience training for mental health workers. Eric is a co-editor of the cutting-edge new textbook, Acceptance and Commitment Therapy and Mindfulness for Psychosis. Check out the website for all the show notes and links Eric spoke about!

Dr Eric Morris is a clinical psychologist and researcher based in Melbourne, Australia. He currently works as the Director of the La Trobe University Psychology Clinic. Previously he worked as a consultant clinical psychologist and the psychology lead for early intervention for psychosis, at the South London and Maudsley NHS Foundation Trust, UK. Eric trained as a clinical psychologist in 1994-1995 at Murdoch University, specialising in psychological interventions for psychosis. On qualifying he worked in a pioneering service for early intervention for psychosis in Perth, Western Australia, before moving to the UK in 1999 to work for the National Health Service in Hampshire and South London. His clinical experience is in providing cognitive-behavioural and family interventions for people recovering from serious mental illness (psychosis, bipolar disorder) and their families. Eric has been practising Acceptance and Commitment Therapy (ACT) for 15 years, including supervising and training therapists in this area. He is a founding member and a former chair of the Acceptance and Commitment Therapy Special Interest Group (ACTSIG) of the British Association for Behavioural and Cognitive Psychotherapies. In 2013 Eric completed his PhD at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, researching psychological flexibility and auditory hallucinations. He also researched ACT as a group-based intervention for people recovering from psychosis, and as a workplace resilience training for mental health workers. Eric is a co-editor of the cutting-edge new textbook, Acceptance and Commitment Therapy and Mindfulness for Psychosis. Check out the website for all the links Eric spoke about and his best self-care tip!  

Parents are key knowledge users of evidence about children’s pain, and more and more are turning to social media for information about child health. Join us as we chat to Dr. Christine Chambers about pediatric pain, the impact of social media on parents with children in pain, and the “It Doesn’t Have to Hurt” social media initiative. It Doesn't Have to Hurt is a unique science-media partnership between health researchers (lead by Dr. Chambers) and an award-winning online publisher targeted primarily to Canadian mothers, Erica Ehm’s Yummy Mummy Club (YMC). Dr. Chambers is a clinical psychologist and Professor in the Departments of Pediatrics and Psychology & Neuroscience at Dalhousie University in Halifax and her research lab is based in the Centre for Pediatric Pain Research at the IWK Health Centre. 

Living a life “on purpose” requires a healthy brain; so Life on Purpose Episode #13 takes us to places we've never gone before on the show! In this fascinating hour-long chat, Dr. Andrew Hill joins us to discuss the newly emerging science of nootropics — supplements and functional foods that improve one or more aspects of mental function such as focus, memory, and motivation. We also talk about NeuroFeedback, a type of biofeedback that uses real-time displays of brain activity such as EEG to teach self-regulation of brain function, as well as neuroplasticity and much more! About: Andrew Hill is a UCLA graduate with a PhD in Cognitive Neuroscience from the department of Psychology, employed as a Lecturer at UCLA, teaching multidisciplinary courses on Healthy Brain Aging, Neuroscience topics, and Biofeedback. He has extensive experience working with clinical and research populations across many areas, including neurodevelopmental, inpatient and outpatient, and people working to overcome substance abuse challenges. Dr. Hill received his PhD in Cognitive Neuroscience from UCLA in 2012, studying how attention operates in the brain. He is currently lecturing for the Undergraduate Education Initiatives program at UCLA, teaching a course sequence gerontology, and the neuroscience of healthy brain aging. Dr. Hill has published chapters on measuring and modulating human attention, and continues to research self regulation. Prior to UCLA, Dr. Hill obtained extensive experience working with both psychiatric and developmental populations as well as gaining experience in high technology areas. He received his B.S. in Psychology/Neuroscience from UMass Amherst. To learn more about Dr. Hill's work, visit: http://www.alternativesbh.com or https://trubrain.com.

The following is a guest post by Dr. Andrew Hill, Lead Neuroscientist at . Click here for a fascinating audio podcast that accompanies this article. featuring Ben Greenfield and Dr. Hill. Dr. Hill received his PhD in Cognitive Neuroscience from UCLA in 2012, studying how attention operates in the brain. He has been employed as a Lecturer at UCLA over the past few years, teaching multidisciplinary courses on both Healthy Brain Aging and courses in Neuroscience and Psychology. Dr. Hill has published chapters on measuring and modulating human attention, and continues to research self regulation. Prior to UCLA, Dr. Hill obtained extensive experience working with both psychiatric and developmental populations as well as gaining experience in high technology areas. He received his B.S. in Psychology/Neuroscience from UMass Amherst, and is a key adviser in the formulation of the (get 20% off on your purchase with the code BEN20). --------------------------------- The Limitless Pill In the , Bradley Cooper’s character gets his hands on a smart drug (NZT-48) that enables him to be cognitively super human. The only known side effect is that his eyes change color while he is on the drug, but that changes over the course of the movie as side effects, including withdrawal symptoms, begin to get worse and worse. It’s a sci-fi thriller with a not-so-feel-good message about addiction and performance enhancing substances. And goons chasing you. Makes smart drugs sound dangerous, right? Like any good sci-fi , this movie questions our assumption on the limits of science. And some of what it is suggesting is not science fiction today. Smart drugs and nootropics are a current reality, being used more and more not to treat or remediate any active condition or complaint but towards boosting already typical or superior performance, in colleges, board rooms, military theatres, and by forward thinking gerontologists. With the wide variety of compounds available today that have some research support for cognitive effects, it is important for you to understand the risks and benefits associated with usage, or at least how to choose smarter, when choosing things that affect your brain. For example, one of the most popular misconceptions about smart drugs is that they are the same as nootropics. This may be due to similar benefits that people use them for, but ultimately they do not share the same range of effects, mechanisms of action, safety and side effects. So - what are smart drugs? What are nootropics? How do we know if something is safe or effective? What are these drugs actually doing to my brain? Why am I asking so many questions without answering them? Keep reading to get this and more information you need to understand these questions, and start formulating your own answers - and your own strategies for selecting nootropics. --------------------------------------- Smart Drugs vs. Nootropics A smart drug is generally a prescribed medication or off-label drug used primarily to treat some kind of mental or cognitive disorder. The most common are drugs such as Adderall (dextroamphetamine) or Ritalin (methylphenidate) in the stimulant class used to treat symptoms related to ADHD - although legal and illegal off-label use is rampant. And while they may promote focus and energy in some people, others have dramatic side effect, to body and brain. Smart drugs in the stimulant class also tend to be reinforcing, producing spikes in dopamine and norepinephrine. This leads to tolerance and habit formation, including adverse effects on appetite, mood stability, cardiac function, stress levels and possibly many other unwanted effects - especially on younger brains such as teens and young adults. Irritability and mood swings, anxiety, sleep issues, and other forms of emotional or cognitive regulation problems can crop up over time with stimulant use, as well. A popular atypical stimulant “smart drug” includes the narcolepsy agents Modafinil / Adrafinil, although their effects on cognition beyond wakefulness are unproven, and side effects - while rare - can be life threatening. If attention problems are already present the side effect risk appears to be significant increased, as well. (). In contrast to a smart drug, a nootropic is generally a non-prescribed compound, including vitamins, herb, other supplements, natural or synthetic compound that may increase or protect cognition in some way. The preponderance of research in the past 40 years shows some effects on focus, attention, effects on aging, and possibly cellular metabolism. To paraphrase the definition of “nootropic” as , it is something that improves cognition without appreciable side effects, or provides from protection to the brain. In a modern context we think of nootropics as something used not to treat any mental condition or pathology directly, but instead to provide support to peak function, protect against long term risk, and provide daily boost. Across the field, true nootropic ingredients and full blends can now be found largely sourced from natural ingredients. Nootropic blends are designed to leverage synergy effects suggested in the research and subjective experiences. The goals with nootropics should always be to allow for greater and more consistent cognitive effort and flow, without the side effects of a stimulant or other harsh substance. ------------------------------ How Do I Know If A Smart Drug Is Safe? As a rule of thumb, it is the nature of science to be wrong at times. We’ve come a long way since we accepted that the theory behind the Earth being the center of the universe was wrong. We understand that new research may overturn old knowledge. So how can we truly know the risks and benefits of long term use of nootropics or smart drugs? A red flag in understanding the harm of a substance is the body’s ability to handle an overabundance of this substance. Small amounts of toxic substances may be beneficial in the short term, but the magic happens when we look at what is happening in the body when we get too much. Something as simple as a cup of coffee may seem harmless, but caffeine in high amounts can cause dizziness, anxiety, and even cardiac arrest or death. Caffeine mimics the action of the neuromodulator adenosine in the body. This leads to higher adrenaline and cortisol levels. Even in typical doses caffeine can deeply affect our sleep and cause heart arrhythmias for some people. Alcohol has even worse short and long term toxicity symptoms at non-moderate doses, and some people struggle to keep their dosing moderate. In better doses - perhaps a couple cups of coffee a day (without sugar) and a drink or so per day on average, these substance are actively health promoting, and reduce risk for many brain and cardiac diseases. When you are picking substances and compounds, dosing should be cautious at first. From this, a couple rules come out - 1) don’t take any compounds, substance, or blends of substances that don’t list all their ingredients out in plain amounts. Proprietary blends with lump-sum amount hiding buzzword-compliant list of magical ingredients known as “fairy dusting” in the supplement industry. Don’t be fooled. Read the ingredients. Figure out why and what is in there, and if you want it. 2) don’t chase suspicious research chemicals without much history of use or safety profile. Experiment on yourself if you like, but you only have one brain - make rational and cautious choices. There are nootropic, smart drug, and cognitive enhancers that have been around for decades - something released last week as a “Research Chemical” with a bunch of numbers and letters for a name and no human studies isn’t worth the risk to you. Not for years. ------------------------------- What About Adderall & Modafinil Safety? Smart drugs such as Adderall can cause dangerous lows, psychosis with extreme use, rebound fatigue, and depression, even at lower use levels. As an amphetamine, Adderall can act as a reuptake inhibitor, meaning that it can compete with other neurotransmitters for reuptake. Specifically it is thought to block the uptake of dopamine and norepinephrine, which are associated with reward behaviors and our nervous system functions, respectively. This causes a flood of these neurotransmitters onto multiple receptors, causing neurotransmitter depletion and overexcited receiving neurons. This large “signal” is the reason for the focus, but also responsible for some of the side effects that go along with this class of prescription drugs. Existing research is also a bit weak on any improvement that Adderall or other stimulants may have on short term memory or cognitive function, and some actually may impair function. Modafinil, also known as Provigil, is an example of a smart drug that has been used like a nootropic. Modafinil is prescribed to treat sleep disorders, but when combined with a normal functioning brain, can potentially cause increases in cognition and awareness. Just like Adderall, the use of these drugs outside the medical field does not make them a nootropic. Modafinil is also a reuptake inhibitor for dopamine, causing the same type of neurotrasmitter flood as Adderall. However, Modafinil may also affect the histaminergic pathway, which deals with wakefulness and the delicate immune response of the body. Histaminergic neurons in the brain are more active during wakefulness and slow their firing pattern as we rest or sleep. Modafinil’s “beneficial” side effects may come from this heightened histaminergic neuronal activation, but too much activation can cause apoptosis, or cell death. In addition, this has been shown to cause adverse skin reactions that required hospitalization since the histamine pathway also deals with our immune system. Modafinil may increase your intelligence, but can be extremely dangerous to the health of your brain and body. ------------------------------- Enter Nootropics Nootropics, , and a few other products on the market, have dose-toxicity levels much lower than salt, caffeine, and especially Adderall. There doesn’t seem to be any neurotransmitter depletion, tolerance or habit forming potential, adverse body side effects, or impaired brain function, from most true nootropics, by Girugea’s definition. The mechanisms for nootropics lie within the structural connectivity of the brain, the optimization of blood flow and oxygenation, and the fortification of brain regions over long term consistency. Nootropics act more as a super supplement to protecting the brain. Girugea’s own first synthesized nootropic (in 1964) is still in use today and has been shown to have effects on mitochondrial metabolism, cell membrane fluidity, and functional connectivity in the brain. Piracetam is this poster child for nootropics, and one of the main ingredients in . It is one of the only compounds used in that formulation that can not be found in nature, however it was originally derived from - and has structural similarities to - the neurotransmitter GABA. Since Girugea bought piracetam to light in 1964, there has been lots of research to support the benefits of piracetam. It has been shown to positively affect our cell membranes and to have neuroprotective and pro-metabolism effects on cells. The fluidity in our membranes changes with stress and old age, as well as moment to moment as one method of regulating receptor activity. By keeping our membranes healthy we can promote the cells ability to communicate. For example, combines other membrane oriented supplements - including choline. The cell membrane - especially in the brain - relays ongoing control signals and messages from other cells to the inner processes of the cell. Neurons’ membranes in the axon (wiring) and soma (cell body) help generate and propagate electrical signals, sum distant signals, and even have computational and complex learning functions related to changes in membrane function.Healthier and more active cell membranes bring us increased activity and cell communication, and hopefully better cognition. Piracetam along with other ingredients such as magnesium, choline, and DHA, increases in brain plasticity and are designed to improve cognition and efficiency under processing load - or peak performance, versus remediation. Nootropics may support increased cognitive potential as well as long term protection. The team added L-Theanine and L-Tyrosine to support neurotransmitters of GABA and Dopamine, respectively. You can use a similar or different strategy when building your own nootropic regimen, but use a strategy. Know why you are putting an ingredient in, know how it might interact with the others, and be sure that dosing is safe. When you are planning your nootropic or nutraceutical regimen, think in terms of nutrition support to cell metabolism and function, amino acids, natural or near-natural compounds, and avoid bad fats and harsh chemicals that give a momentary boost at the cost of later crashing or having other more serious side effects, such as excess sugars and caffeine. And don’t forget what else you put in your mouth - additional DHA and other omega-3 fatty acids (in grass fed meats, deep sea fish) are excellent for brain health. Craft your diet like you craft your brain supplement regimen - or have both catered / curated for you in a high end product. If you do create your own blend, think precise selection, not shotgun approach, and add slowly to your regimen. -------------------------------- The Problem With Instant Gratification As a culture, we often hear false marketing claims or create mindsets about what is possible with our health. We see ads that advertise a pill that gets rid of “stomach fat fast”. Truthfully, fat is lost uniformly in the body and the fastest and healthiest way to lose weight it about 1-2 pounds uniformly a week. So we eat poorly and don’t exercise for 2 years and then criticize our healthy workout plans and diet 1 month in when we don’t get the results we want. The healthiest and most effective things in life are often the ones that we do routinely. Consistency is key. This is true if you are talking about athletic performance, academic or intellectual training, or nutrition and supplement support. While not “necessary” like supplements or medicines, nootropic use follows this principle as well. There is another rule, emerging. If something is strongly “felt” dose to dose - if it gets you high, or wired, or sedated...it’s a smart drug, recreational drug, or something that may enhancing some aspect of performance (perhaps at the expense of another), but is definitely not a nootropic. And finally, nootropics should be sustainable. With some nootropics there is an initial loading phase followed by a maintenance phase, and while subtle, results can be felt fairly quickly on the timescale of a few days. The contrasting quick highs / crashes of coffee, alcohol, smart drugs, and even quickly digesting carbs are definitely experienced more immediately, but have consequences that make them unsustainable for many people. ------------------------------ Summary So in summary - here are a few initial rules to help select your own nootropic or cognitive enhancing blend: Know your ingredients, and their amounts. Don’t spend your money on obfuscate fairy dusting or expensive blends that are full of caffeine or random research chemicals. It’s not a nootropic if it has side effects. Your nootropic solutions should focus on mild nutritive and metabolic support, for long term gains and protection. Break the cycle peak and crash that you get with too many stimulants, and avoid the more serious side effects that you risk with smart drugs. Nootropics don’t get you high, altered, or wired. And don’t forget the other accessible and evidence-based brain and cognition improving methodologies we have at our disposal today: meditation, yoga, and other contemplative (attention training) practices, biofeedback and neurofeedback, diets high in good fats, and other modifiable behaviors you can implement to take control of your brain health and performance. So take care of your brain - the tools are out there, to support health and shift performance. Leave your questions, comments and feedback at . Also, if you want to try the nootropic that Dr. Hill helped design, and get 20% off on your purchase with the code BEN20.

"The Living Dead Brain: What human brains teach us about zombie minds" The realities of modern neuroscience once only existed in the imaginations of science fiction authors. Brain signals can control robotic arms or make music, viruses are being used to reprogram neurons to fire when exposed to light, and giant magnets are capable of visualizing our thoughts in action. Join Dr. Timothy Verstynen (Assistant Professor in Psychology & Neuroscience at Carnegie Mellon University) as he turn the tables and shows how real science can be used to explain science fiction. Using forensic neuroscience, Dr. Verstynen will demonstrate how the behavior of horror movie zombies (e.g., the way they move, their inability to talk or experience pain) can be understood as a surreal convergence of neurological impairments. This educational talk is designed to highlight how popular culture can be leveraged as a useful teaching tool for science education at all ages. Recorded on Monday, June 3, 2013 at Carnegie Science Center

This is the Q&A portion of Dr. Timothy Verstynen's talk, "The Living Dead Brain: What human brains teach us about zombie minds" The realities of modern neuroscience once only existed in the imaginations of science fiction authors. Brain signals can control robotic arms or make music, viruses are being used to reprogram neurons to fire when exposed to light, and giant magnets are capable of visualizing our thoughts in action. Join Dr. Timothy Verstynen (Assistant Professor in Psychology & Neuroscience at Carnegie Mellon University) as he turn the tables and shows how real science can be used to explain science fiction. Using forensic neuroscience, Dr. Verstynen will demonstrate how the behavior of horror movie zombies (e.g., the way they move, their inability to talk or experience pain) can be understood as a surreal convergence of neurological impairments. This educational talk is designed to highlight how popular culture can be leveraged as a useful teaching tool for science education at all ages. Recorded at the Carnegie Science Center in Pittsburgh, PA on Monday, June 3, 2013